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1 © European Food Safety Authority, 2011 
SCIENTIFIC OPINION 
Scientific Opinion on the maintenance of the list of QPS biological agents 
intentionally added to food and feed (2011 update)1 
EFSA on Biological Hazards (BIOHAZ)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
EFSA is requested to assess the safety of a broad range of biological agents (including microorganisms and 
viruses) in the context of notifications for market authorisation as sources of food and feed additives, enzymes 
and plant protection products. The qualified presumption of safety (QPS) assessment was developed by EFSA for 
its own use to provide a generic risk assessment approach applicable across EFSA’s scientific Panels, for 
biological agents notified for intentional use in the whole food chain. The safety of unambiguously defined 
biological agents at the highest taxonomic unit that is appropriate for the purpose for which an application is 
intended and the completeness of the body of knowledge are assessed. Identified safety concerns for a taxonomic 
unit are where sensible reflected as ‘qualifications’ when a recommendation for the QPS list is given. The list of 
QPS recommended biological agents is reviewed and updated annually. Therefore, the only valid list is the one in 
the most recent scientific opinion. The 2011 update reviews microorganisms previously assessed including 
bacteria, yeasts, filamentous fungi and viruses used for plant protection purposes and confirms the previous 
recommendations. The anamorph yeast form Phaffia rhodozyma of Xanthophyllomyces dendrorhous was 
included on the QPS list and to the qualification for yeasts ‘absence of resistance to antimycotics used for 
medical treatment of yeast infections’, the sentence was added that ‘in the case of Saccharomyces cerevisiae this 
qualification applies for yeast strains able to grow above 37 °C’. The body of knowledge of filamentous fungi 
and enterococci was updated and their ineligibility for the QPS list confirmed.   
© European Food Safety Authority, 2011 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to 
deliver a Scientific Opinion on the maintenance of the list of QPS biological agents (microorganisms 
and viruses) intentionally added to food or feed (2011 update). The question included five specific 
tasks.  
The first required the preparation of an update of the list of biological agents notified to EFSA for 
safety assessment. This should be a starting point for identifying new taxonomic units for review 
under the QPS assessment. Only those taxonomic units relevant to current legal requirements in the 
context of notification to EFSA for intentional use in feed and/or food or as sources of food and feed 
additives, enzymes and plant protection products shall be included. The list was updated with the 
notifications received where applicable by EFSA Panels and Units since the last review.  
The second aspect was concerned with an annual review of the list of biological agents recommended 
for the QPS list. Where appropriate new taxonomic units should be assessed for their suitability for an 
inclusion in the QPS list, and taxonomic units previously assessed should be reviewed where new 
information has become available. The information provided in the previous opinion should be 
updated where appropriate.  
The BIOHAZ Panel confirmed all taxonomic units previously recommended for the QPS list. The 
information of the previous opinion was updated for the taxonomic units on the QPS list. The 
notifications were assessed and no new recommendations for the QPS list were made.  
An assessment of three new bacterial species (Ensifer adhaerens and Ensifer fredii, 
Ketogulonicigenium vulgare, Clostridium butyricum), a new yeast species (Trichosporon 
mycotoxinivorans) and several additional fungi species (Ampelomyces quisqualis, Ashbya gossypii, 
Aspergillus aculeatus, Trichoderma asperellum, Trichoderma longibrachiatum for enzyme 
production, Trichoderma viride for enzyme production) was performed but these species were not 
included on the QPS list.  
Phaffia rhodozyma the imperfect form of Xanthophyllomyces dendrorhous was included on the QPS 
recommended list. In accordance with the most recent taxonomic revision of yeasts, the new name of 
Pichia jadinii was changed to Lindnera jadinii. 
Tasks three and four required, for the taxonomic units included in the QPS recommended list, a 
review and update of knowledge concerning antimicrobial resistance and a review of the 
qualifications. The information of the previous opinion was updated by the BIOHAZ Panel for 
bacteria and the qualification on antimicrobial resistance was confirmed.  
For the yeast the knowledge on antimycotic resistance was updated and the qualification ‘on absence 
of resistance to antimycotics used for medical treatment of yeast infections’ was complemented by the 
sentence ‘in the case of Saccharomyces cerevisiae this qualification applies for yeast strains able to 
grow above 37 °C’. This qualification is only relevant if viable yeasts are intentionally introduced into 
the food chain and it was restricted to those yeast species for which information on antifungal 
susceptibility exists. 
The final aspect included a review of the body of knowledge for filamentous fungi and enterococci. 
The BIOHAZ Panel updated the knowledge of filamentous fungi notified for EFSA. Although 
numerous data, published since the 2010 QPS opinion, have contributed to partially fulfil gaps of 
knowledge, too many unknowns remain in 2011 to allow a filamentous fungus to be qualified as QPS. 
Enterococci cannot be considered for the QPS list based on the current scientific knowledge. 
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BACKGROUND AS PROVIDED BY EFSA 
A wide variety of bacterial and fungal species are used in food and feed production, either directly or 
as a source of additives or food enzymes. Some of these have a long history of apparent safe use, 
while others are less well understood and may represent a risk for consumers. Experience has shown 
that there is a need for a tool for setting priorities within the risk assessment of those microorganisms 
used in the production of food/feed which are captured by present legislation and consequently the 
subject of a formal safety assessment.   
In 2002/3 a working group consisting of members of the former Scientific Committees on Animal 
Nutrition, Food and Plants of the European Commission proposed the introduction for selected 
microorganisms of a Qualified Presumption of Safety (QPS)4.  
In April 2003, responsibility for the safety assessments of food/feed undertaken by the Scientific 
Committees of the Commission formally passed to the European Food Safety Authority (EFSA). 
Shortly after EFSA asked its own Scientific Committee to consider whether the approach to safety 
assessment of microorganisms proposed in the QPS document could be used to harmonise approaches 
to the safety assessment of microorganisms across the various EFSA scientific panels.  
The Scientific Committee concluded that QPS as a concept could provide a generic approval system 
for use within EFSA that could be applied to all requests received for the safety assessments of 
microorganisms deliberately introduced into the food chain5. The benefits of the introduction of QPS 
would be a more transparent and consistent approach across the EFSA panels and the potential to 
make better use of resources by focussing on those organisms which presented the greatest risks or 
uncertainties.  The Scientific Committee reviewed the range and numbers of microorganisms likely to 
be the subject of an EFSA Opinion and published a list of microorganisms recommended for QPS6.  
The Scientific Committee recommended that a QPS approach should be implemented across EFSA 
and applied equally to all safety considerations of microorganisms that EFSA is required to assess. In 
reaching its conclusion on the value of QPS as an assessment tool, the Scientific Committee 
recognised that there would have to be continuing provision for reviewing and modifying the list of 
organism given QPS recommendation. They recommended that the EFSA via its Panel on Biological 
Hazards (BIOHAZ) should take prime responsibility for this and should review the existing QPS list 
and any additions at least annually. Reviews may occur more frequently as necessary but there should 
be a formal requirement that even when no changes are proposed, a statement should be made 
annually that QPS recommendation is being maintained for the published list. 
                                                     
 
4 See http://ec.europa.eu/food/fs/sc/scf/out178_en.pdf 
5 See www.efsa.europa.eu/en/science/sc_commitee/sc_opinions/972.html 
6 See www.efsa.europa.eu/en/scdocs/scdoc/587.htm 
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In the first annual QPS review and update7, the existing list of QPS microorganisms was reviewed and 
EFSA’s initial experience in applying the QPS approach was described. In addition, following the 
identification of antimicrobial resistance as a universal qualification of safety in the previous 
Opinions on QPS, the issue was addressed in line with the opinion developed by the BIOHAZ Panel8 
on ‘Foodborne antimicrobial resistance as a biological hazard’, and related documents9,10,11 of other 
EFSA Panels. The potential application of the QPS approach to microbial plant protection products 
was discussed in the most recent reviews 12,13. 
The 2009 update9 reviews the previously assessed microorganisms including bacteria, yeasts and 
filamentous fungi and assesses several additional notifications concerning gram-positive and gram-
negative bacteria and yeasts. Lactobacillus cellobiosus, Lactobacillus collinoides, Propionibacterium 
acidopropionici and Oenococcus oeni were included in the QPS list. No filamentous fungi were 
included because of potential production of toxic metabolites in line with previous QPS assessments3.  
For the first time viruses were assessed. Insect viruses (Baculovirideae) and in the case of zucchini 
yellow mosaic viruses the Potyvirideae family as the highest possible taxonomic unit were added to 
the QPS list. Bacteriophages were considered as not appropriate for the QPS list. A potential presence 
of antimycotic resistance of yeasts referred to on the QPS list was considered. It was concluded that 
yeast strains resistant to antimycotics used for treatment of infections in humans might be of public 
health concern.   
In the last QPS update in 201013 the previously assessed microorganisms including bacteria, yeasts, 
filamentous fungi and viruses used for plant protection purposes were reviewed and the QPS 
recommendations of the previous year were confirmed. Qualifications, intended to exclude potential 
safety concerns, relating to the agents recommended for the QPS list were also reviewed, clarified and 
updated where necessary. Specific sections dealing with antibiotic resistance relevant for QPS 
recommended microorganisms were included. The methodology used for carrying out the annual 
review of the list of QPS recommended biological agents was detailed. A list of microbial species 
from previous notifications and as notified to EFSA, annexed in this opinion, included information on 
taxonomic units which are or are not recommended for the QPS list with the rational for this decision. 
This list of notifications aims to summarize and maintain important information for future 
assessments and updates and is intended to be updated annually. 
                                                     
 
7 Opinion of the Scientific Panel on Biological Hazards on a request from EFSA on the maintenance of the list of QPS 
microorganisms intentionally added to food or feed. The EFSA Journal (2008) 923, 1-48.  
8 Opinion of the Scientific Panel on Biological Hazards on a request from EFSA on foodborne antimicrobial resistance as 
a biological hazard. The EFSA Journal (2008) 765, 1-87. 
9  Technical guidance prepared by the Scientific Panel on Additives and Products or Substances used in Animal Feed 
(FEEDAP) on the update of the criteria used in the assessment of bacterial resistance to antibiotics of human or 
veterinary importance. The EFSA Journal (2008) 732, 1-15. 
10  Guidance Document of the Scientific Panel on Genetically Modified Organisms for the Risk Assessment of Genetically 
Modified Microorganisms and their Derived Products Intended for Food and Feed Use. The EFSA Journal (2006) 374, 
1-115. 
11 EFSA, 2010. Public consultation on: "Guidance on the risk assessment of genetically modified microorganisms and their 
food and feed products". Published on EFSA’s website: 29 November, 2010; deadline: 24 January, 2011. 
www.efsa.europa.eu/en/consultations/call/gmo101129.htm 
12  Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) on the maintenance of the list of QPS microorganisms 
intentionally added to food or feed (2009 update). The EFSA Journal (2009), 7(12): 1431 
13 Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) on the maintenance of the list of QPS biological agents 
intentionally added to food or feed (2010 update). EFSA Journal 2010; 8(12):1944 
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TERMS OF REFERENCE AS PROVIDED BY EFSA 
 
EFSA requests the BIOHAZ Panel to: 
 
1. Preparation of an update of the list of biological agents notified to EFSA for safety assessment. 
This should be a starting point for identifying new taxonomic units for review under the QPS 
assessment. Only those taxonomic units relevant to current legal requirements in the context of 
notification to EFSA for intentional use in feed and/or food or as sources of food and feed 
additives, enzymes and plant protection products shall be included. 
2. Annual review of the list of biological agents recommended for the QPS list. Where appropriate 
new taxonomic units should be assessed for their suitability for an inclusion on the QPS list, and 
taxonomic units previously assessed should be reviewed where new information has become 
available. The information provided in the previous opinion should be updated where appropriate. 
3. Review and update of knowledge concerning antimicrobial resistance in taxonomic units 
recommended for the QPS list. 
4. Review of the qualifications for taxonomic units included in the QPS recommended list. 
5. Review of the body of knowledge for filamentous fungi and enterococci. 
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ASSESSMENT 
1. Introduction 
A wide variety of microorganisms are intentionally added at different stages into the food chain, 
either directly or as a source of additives or enzymes. In this context, approximately 100 species of 
microorganisms have been expected to be referred to EFSA for a safety assessment. The majority are 
the result of notifications for market authorisation as sources of food and feed additives, food 
enzymes and plant protection products received by EFSA. 
The purpose of the present Opinion is to review the list of previously Qualified Presumption of Safety 
(QPS) recommended biological agents which was last established in 2010 (EFSA, 2010). The QPS 
approach was developed by the Scientific Committee to provide a generic concept to prioritise and to 
harmonise risk assessment of microorganisms intentionally introduced into the food chain within 
EFSA in support of the respective Scientific Panels and Units in the frame of authorisations (EFSA, 
2007). The list, first established in 2007 is to be reviewed annually (EFSA, 2007). Taxonomic units 
were included in the QPS list either following notifications to EFSA or following proposals made 
during a public consultation in 2005 by stakeholders, even if they were not yet notified to EFSA 
(EFSA, 2005).   
1.1. QPS an assessment approach for use within EFSA  
QPS as a concept could provide a generic approval system for use within EFSA that could be applied 
to all requests received by EFSA for the safety assessments of microorganisms deliberately introduced 
into the food chain. Its introduction would make the risk assessment approach more transparent across 
the EFSA Scientific Panels and Units. It would aid the consistency of assessment and make better use 
of resources by focussing on those organisms which present the greatest risks or uncertainties (EFSA, 
2005). 
In the QPS concept a safety assessment of a defined taxonomic unit is considered independently of 
any particular specific notification in the course of an authorisation process. If the taxonomic unit 
does not raise any safety concerns, or if existing safety concerns can be clearly defined as specific 
qualifications to ensure their absence (exclusion) in the context of a specific notification, a particular 
taxonomic unit could be recommended for the QPS list. Subsequently, any specific representative of a 
QPS proposed taxonomic unit, would not need to undergo a further safety assessment other than to 
satisfy any of the qualifications specified if applicable. Representatives of groups that fail to satisfy a 
qualification would be considered unfit for the QPS list and would remain subject to a full safety 
assessment, in the frame of a notification within the responsible EFSA Scientific Panel (EFSA, 2007). 
The QPS concept does not address hazards linked to the formulation or processing of the products 
based on biological agents added into the food or feed chain. These aspects are assessed, where 
applicable, separately by the EFSA Panel responsible for assessing the notification. 
Concerning microorganisms discussed in previous Opinions, the continuously evolving body of 
knowledge possibly reveals new information that could lead to a modification of the list of QPS 
recommended taxonomic units, for example to an ex- or inclusion of taxonomic units on the list. An 
assessment of taxonomic units, not previously considered for the QPS list, and for which 
representatives are notified to EFSA is also discussed. These include, beside microorganisms, viruses 
used in the context of plant protection and bacteriophages. Consequently, the QPS 2011 update will 
review these biological agents. Biological agents intended for usages outside the remit of EFSA, and 
biological agents which have not been notified to EFSA, are not considered in this Opinion. 
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In 2008 antimicrobial resistance was introduced as a possible safety concern for the assessment of the 
inclusion of bacterial species in the QPS list (EFSA, 2008a). In the 2009 and 2010 Opinions (EFSA, 
2009, 2010) a qualification regarding absence of antimycotic resistance for yeast was introduced. The 
qualifications are reviewed and discussed in the present Opinion.  
In accordance with the recommendation by the Scientific Committee that the QPS concept should be 
implemented within EFSA where relevant, an impact assessment of the QPS system by EFSA Units in 
the frame of authorisations and its quotation in the scientific literature is provided.    
1.2. Experience of using the QPS approach within EFSA  
The QPS approach has proved to be a useful tool to harmonise and prioritise safety assessment within 
EFSA and is appreciated by both assessors and applicants. The QPS recommended list was mainly 
used by the EFSA’s Panel on Additives and Products of Substances used in Animal Feed (FEEDAP). 
If a biological agent is recommended for the QPS list this covers in their assessment as well safety for 
consumers, animals and the environment. Neither safety of users handling the product nor genetic 
modifications are taken into account. In the respective FEEDAP Opinions dealing with QPS 
recommended microorganisms a standard sentence is included that the active agent in question is 
considered by the European Food Safety Authority (EFSA) to be suitable for the Qualified 
Presumption of Safety (QPS) approach to safety assessment. Therefore, no assessment of safety for 
the target species, consumer and the environment is required. Until 7th October 2011, the QPS 
approach has been applied by FEEDAP, in the assessment of 20 dossiers out of a total of 22 published 
opinions concerned with a safety assessment of microorganisms as feed additives (EFSA, 2011a-t).  
The annual QPS updates provide relevant new information from the literature for biological agents 
currently under peer-review which, if showing more critical or adverse effects, will be taken into 
account during the process of the peer-review or in the EFSA conclusion. When a microorganism is 
approved under Regulation (EC) No 1107/2009 (Official Journal of the European Union, 2009), a 
cycle of 10 to 15 years is foreseen for the revision of the dossier including new information according 
to the regulatory framework. This shows the usefulness of the QPS approach as a mean of regularly 
updating the body of knowledge on taxonomic units of importance for EFSA Panels and Units, even if 
they are not on the QPS list. Hence, the annual update of the body of knowledge concerning fungi is 
appreciated by the Pesticide Unit.  
Biological agents recommended for the QPS list and proposed as plant protection products (under the 
Directive 91/414/EC (Official Journal, 1991) could be exempt from certain data requirements such as 
oral toxicity data. However, the QPS recommendation does not address other risks, specifically risks 
for the user and risks for the environment, which have to be assessed specifically for plant protection 
products according to the Regulation (EC) No 1107/2009 (Official Journal of the European Union, 
2009). The activity of maintenance of the QPS list has also been communicated to the Pesticide 
Steering Committee in March 2011.  
1.3. Reference to QPS in the scientific literature 
Since the publication of the EFSA 2010 Opinion (EFSA, 2010) which cited and discussed references 
to the QPS approach in the scientific literature, additional references were made to the concept. Those 
published by the end of July 2011 were collected. Some publications refer to documents which seem 
to make reference to other documents than those published by EFSA (Delorme et al., 2010; Forssten 
et al., 2011a; b; Izawa et al., 2011; ), others refer to initial QPS documents published by EFSA 
(reports and opinion up to 2007) rather than to the recently updated QPS opinions (Aureli et al., 2011; 
Ayeni et al., 2011; Cintas et al., 2011; Doyle and Erickson, 2011; Engel et al., 2011; Kneifel, 2011; 
Mayrhofer et al., 2011; Moslehi-Jenabian et al., 2010; Salazar et al., 2011; Saxelin et al., 2011; Seitter 
et al., 2011; Talon and Leroy, 2011) while some refer to more recent QPS opinions as of 2008 
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(Chanos and Williams, 2011; Chenoll et al., 2010; Clementi and Aquilanti, 2011; Cousin et al., 2011; 
Ferreira et al., 2011; Johnsson Holmsberg, 2011; Klein, 2011a; Meieregger et al., 2011; Ouwehand et 
al., 2011; Patel et al., 2010; Sundh and Melin, 2011).  
The list of QPS recommended biological agents is reviewed and updated annually therefore the only 
valid list is the one from the most recent scientific opinion.  
Other publications appear to mention the QPS assessment without any reference (Sanders and Levy, 
2011; Schroeder et al., 2011; Xu et al., 2011) and some of these seem to suggest a change of QPS 
recommendations such as for example for Streptococcus thermophilus (La Gioia et al., 2011). Fjelsted 
and Ehlers (2011) specifically discuss the QPS approach as a tool to support the registration process 
of biological control agents used in agriculture. It should be noted that the QPS approach is used for 
risk assessment only within EFSA. 
Few publications refer to the QPS assessment in analogy with the Generally Recognised As Safe 
(GRAS) concept used in the United States (Ladero et al., 2011; Pilet and Leroi, 2011; Zago et al., 
2011) and it has to be clearly emphasised in that the QPS assessment is different in its overall aim and 
use.  
2. Methodology 
A literature review was carried out for each taxonomic unit that was notified to EFSA either for the 
QPS Opinions in 2007, 2008a, 2009 and 2010. QPS recommended taxonomic units (Table 1) and 
those which represent an important part of the notifications are annually reviewed. The time period of 
the review covered is the beginning of June 2009 until 15 April 2011 for the QPS 2011 update. 
Databases searched are specified in the specific sections. Keywords used are equally specified in the 
specific section however some common keywords such as the taxonomic unit in combination with 
‘toxin’, ‘disease’, ‘infection’, ‘clinical’, ‘virulence’, ‘antimicrobial/antibiotic/antimycotic resistance’, 
‘safety’, ‘risk’, ‘abortion’, ‘urinary’, ‘mastitis’, ‘syndrome’, ‘vaginitis’ and the animal categories 
‘poultry’, ‘chicken’, ‘hen’, ‘broiler’, ‘turkey’, ‘fowl’, ‘piglet’, ‘pig’, ‘calf’, ‘calves’, ‘cattle’, ‘cow’, 
‘fish’ and ‘salmon’ were generally applied. Relevant studies were evaluated, reported and discussed.  
2.1.1. Taxonomy 
2.1.1.1. Bacterial taxonomy 
Taxonomy and nomenclature of bacteria is covered by the International Code of Nomenclature of 
Bacteria (Anonymous, 1992). New taxonomic units or alteration to the taxonomy and nomenclature 
are published in the International Journal of Systematic and Evolutionary Microbiology (IJSEM). In 
this journal a list appears, where all validly published taxonomic units are listed in the Notification 
List, i.e. the Approved List of Bacterial Names. Validly published are all taxonomic units, which are 
published in the IJSEM. Taxonomic units that were published outside the IJSEM are called 
effectively published. They appear after notification by the authors in a Validation List. Also changes 
in nomenclature are listed separately. These can be spelling errors in the original description or 
decisions of the Judicial Commission. A comprehensive and uptodate presentation of the current 
taxonomy and nomenclature of bacteria is given on the following website: LPSN (List of Prokaryotic 
names with Standing in Nomenclature Formerly List of Bacterial names with Standing in 
Nomenclature (LBSN) (Anonymous, 2011). 
2.1.1.2. Yeast taxonomy  
Rules for taxonomy of the yeasts fall under the authority of the International Code of Botanical 
Nomenclature which represents the official reference to validate yeast species. The most recent 
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version of the Code (McNeill et al., 2006) was adopted at the Seventeenth International Botanical 
Congress, Vienna, Austria, 2005. The following is a brief discussion of the Botanical Code as it 
applies to yeasts. Recently, the fifth edition of ‘The Yeasts, a Taxonomic Study’ (Kurtzman et al., 
2011) represents the latest revision of the yeast taxonomy and has incorporated the consensus view of 
the International Code of Botanical Nomenclature. Currently, there are 149 genera and nearly 1500 
species. The application of gene sequence analysis is largely responsible for the increase in the 
number of taxa.  
2.1.1.3. Fungi taxonomy  
As of now the nomenclature and taxonomy of fungi is covered by the International Code of Botanical 
Nomenclature (ICBN) updated in 2005 (McNeill et al., 2006). New taxa or new taxonomic opinions 
are published in the international scientific literature following the rules of ICBN. Due to an intensive 
promotion by leading mycologists and International Mycological Association (IMA) it is now 
common practice to submit new taxonomic units and changes to MycoBank 
(http://www.mycobank.org) to avoid duplication of names and, in part, a quality check of the 
formalities. MycoBank is also a useful source for validity of published names, however information 
on synonyms is not complete as it is a matter of subjectivity. For a few genera lists of currently 
accepted names in use are available, but these have no official status. Article 59 in ICBN permits dual 
nomenclature of pleiomorphic fungi, which has caused some frustrations, as there is no logical link 
between two nomenclatural entities, except the organism, the fungus. The development in molecular 
data has proposed a new view on many anamorph-teleomorph connections and has also initiated an 
action to eliminate the dual nomenclature in mycology, however not all mycologists support this. The 
action towards one fungus should only has one name is presented by Hawksworth et al. (2011) and 
will be debated at the Botanical Congress August 2011.   
2.1.1.4. Virus taxonomy 
The taxonomy and nomenclature of viruses is the responsability of the International Committee on 
Taxonomy of Viruses (ICTV, www.ictv.online; Anonymous, 2010). Every three years an update is 
made based on proposals of working groups after adoption by the Executive Committee. The most 
recent update is from November 2011 (King et al., 2011). Virus taxonomy is based on shared 
characteristics such as (i) the type of nucleic acid (RNA or DNA), (ii) the structure of the nucleic acid 
(single-stranded or double stranded RNA or DNA), (iii) the polarity of the nucleic acid (positive 
stranded = translatable into proteins; negative stranded = nontranslatable into proteins) and (iv) the 
form of the virus (isometric, rod-shaped, filamentous or pleiomorph). In addition to these characters, 
the replication strategy of the viruses is also taking into account and contributes to their taxonomic 
position (Baltimore, 1971; Baltimore, 1974). Viruses are organized in orders (-virales), families (-
viridae), genera (-virus) and species (-virus) by virtue of shared characteristics as described above. In 
contrast to organisms viruses do not have a common ancestor; therefore phylogenetic information is 
only partially useful in directing the taxonomy of viruses. 
 
Plant virus taxonomy 
 
Plant viruses cause disease in plants and many of these viruses are transmitted by vectors (insects, 
nematodes, fungi). The large majority of plant viruses contain positive stranded (= directly 
translatable) RNA as genetic information. About 1,000 plant virus species have been recognized and 
accommodated into two orders and 20 families (Mayo, 1999; www.ictvonline.org; Anonymous, 
2010). 
 
Baculovirus taxonomy  
 
Baculoviruses are large DNA viruses occurring in members of the insect orders Lepidoptera (moths 
and butterflies), Hymenoptera (sawflies) and Diptera (flies). The family Baculoviridae is subdivided 
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into four genera, Alphabaculovirus, Betabaculovirus, Gammabaculovirus and Deltabaculovirus (Jehle 
et al., 2006). Fourty-two baculoviruses have been recognized as a species (as of July 2011, 
www.ictvonline.org; Anonymous, 2010), but about 700 different baculoviruses have been described. 
Baculoviruses have a common ancestor assisting in the assignment of their taxonomic status.  
2.1.2. Qualification regarding antimicrobial resistance in bacteria 
The assessment of antimicrobial resistance in the frame of a specific notification is within the 
responsibility of the EFSA Scientific Panel or Unit which to which the notification was assigned. The 
QPS WG aims to provide general background information for their consideration and support. In 
particular, the generic qualification for all bacterial taxonomic units on the QPS recommended list 
that the strains should not harbour any acquired antimicrobial resistance genes to clinically relevant 
antibiotics (Table 1) is reviewed. A recent EFSA review concluded that for EFSA as a whole, the use 
of interpretative criteria and methods to define and monitor antimicrobial resistance have been 
harmonised and are reflected in EFSA’s guidance documents. The use of harmonised methods and 
epidemiological cut-off values ensures the comparability of data over time at country level, and also 
facilitates the comparison of the occurrence of resistance between MSs (EFSA, 2011u). 
Absence of acquired genes coding for antimicrobial resistance for QPS recommended bacterial 
taxonomic units is a generic qualification. Generally, it has been considered for the QPS approach that 
strains carrying acquired resistances should not be intentionally introduced into the food and feed 
chain. The scope and search for the review of antimicrobial resistance is to conduct a review of each 
taxonomic unit recommended for the QPS list as it was done last year. It was noticed during the last 
QPS update (EFSA, 2010) that the quality of the studies regarding antimicrobial resistance vary a lot.  
Following discussions, it seemed best to consider everything that is available and subsequently 
discuss potential week points in the available studies. 
Suggested general search terms: susceptibility, resistance, antimicrobial, antibiotic. Additional search 
terms are related to acquired resistance genes in line with the generic qualification on ‘not harbouring 
any acquired antimicrobial resistance genes’. These are: tet, bla, vanA, vanB, vanD, vanE, vanG, vanL 
vanM, aac, aph, aad, arm,  rmt, erm, lnu, vat, vga, ere, mef, mre, msr, mph, lin, lsa, cfr, sul, dhfr, cat, 
flo, qep, qnR, oqxAB . 
A point of reference for the update is the FEEDAP guidance document ‘update of the criteria used in 
the assessment of bacterial resistance to antibiotics of human or veterinary importance’ (EFSA, 
2008b). This guidance document was a starting point and was used to subsequently fill any gaps 
during this review where possible. The list of antibiotics and the breakpoints are still valid. Focus 
shall be targeted towards: the presence of an acquired gene in relevant species, genera and if some 
new resistance mechanisms became known. New available information should be taken into 
consideration in this context.  
3. Gram-positive non-sporulating bacteria 
3.1.1. Antimicrobial resistance aspects of QPS lactic acid bacteria in general 
Antimicrobial resistance is also an issue in lactobacilli and other lactic acid bacteria (LAB) and 
should be assessed according to international standards and guidelines (e.g. ISO/DIS 10932/IDF223, 
2010) and Clinical and Laboratory Standards Institute (CLSI) guidelines (Anonymous, 2007)). For the 
purpose of QPS the FEEDAP guidance document (EFSA, 2008b) is of relevance. 
There are several reviews and studies describing the antibiotic resistance of Lactobacillus species as 
well as other LABs (Hummel et al., 2007; Kastner et al., 2006; Klare et al., 2007; Klein, 2011b; Liu et 
al., 2009; Zonenschain et al., 2009). Intrinsic resistance could be shown mainly for aminoglycosides, 
quinolones, and glycopeptides (Hummel et al., 2007; Klein, 2011b). Moreover, the transfer of 
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antibiotic resistance within LAB isolates from food has been recently studied (Nawaz et al., 2011; 
Toomey et al., 2010). Presence of genes coding for antibiotic resistances, such as tet (including 
tet(M), tet(O), tet(S), tet(W), tet(K), and tet(L)); erm (including erm(A), erm(B),and erm(C)) 
(Hummel et al., 2007; Ammor et al., 2008) have been reported. This is a non-comprehensive list. 
3.1.2. Bifidobacterium species 
No case reports could be retrieved by literature search within Pubmed and the respective search terms. 
Only one report pointing on the relevance of Bifidobacterium spp. and also Scardovia and 
Parascardovia for severe early childhood caries (Kanasi et al., 2010) could be found on the clinical 
relevance of bifidobacteria. This is a confirmation of earlier reports for caries in general, but no 
specific taxonomic units within the bifidobacteria were identified. The relevance of bifidobacteria in 
the development of dental caries is comparable to lactobacilli and the same conditions apply as 
reported under section 3.1.5. Therefore, the QPS recommendation is confirmed.  
3.1.2.1. Antimicrobial resistance aspects regarding the qualification 
A recent paper about ‘medium level’ tetracycline resistance in Bifidobacterium animalis subsp. lactis 
showed the presence of tet(W) gene (Gueimonde et al., 2010). The tet(W) gene was  associated with 
the tetracycline resistance in this subspecies. Several tet genes have been already described to be 
present in bifidobacteria, including tet(W) gene (Gueimonde et al., 2010). The relevance for 
Bifidobacterium animalis subsp. lactis lies in the wide distribution of this species within food. There 
is no new information that would require a modification in the qualification of the antimicrobial 
resistance. 
3.1.3. Corynebacteria 
A literature review did not reveal new information about adverse health effects or on safety concerns 
since the last update (EFSA, 2010). The QPS recommendation has been confirmed. 
3.1.3.1. Antimicrobial resistance aspects regarding the qualification 
While no actual antibiotic MIC determinations for Corynebacterium glutamicum appear to have been 
done, the antibiotic sensitivity of a strain used for amino acid production, has been tested using a disc 
method (Costa-Riu et al., 2003). The strain was sensitive to ampicillin, kanamycin, streptomycin, 
tetracycline, susceptible to gentamicin and resistant to norfloxacin, and chloramphenicol. However, 
the susceptibility test was not performed according to the methodology recommended by the CLSI 
guideline (Anonymous, 2007). There is no new information that would require a modification in the 
qualification of the antimicrobial resistance. 
3.1.4. Enterococcus species 
Enterococci are commensal bacteria of the gastrointestinal tract of humans and other mammals, and 
are frequently found as members of the bacterial communities of food fermentations.  Taxonomy of 
this genus has evolved, and currently, more than 30 species have been described.  Among these, 
Enterococcus faecium is the most encountered species in food fermentations, such as cheese, 
fermented vegetable and sausages. This microorganism is also intentionally introduced in the food 
chain as feed additive (animal probiotic), under a specific EU regulation which requires risk 
assessment by EFSA, or as food starter culture (Official Journal of the European Union, 2003).   
Enterococcus faecium is also an important cause of infections in hospitalized or immunocompromised 
patients and the high prevalence of antimicrobial resistance in strains, limits the therapeutic 
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treatments. A new literature search within Pubmed, restricted to the last 12 month, confirmed this 
view with an increase number of reported infections casused by drug resistant Enterococcus faecium. 
The assessment of Enterococcus faecium for QPS has been performed by EFSA in 2010 (EFSA, 
2010), reaching the conclusion that a strain specific evaluation is necessary to assess the risk 
associated to the intentional use of enterococci in the food chain.   
Available scientific data support the view that safety of Enterococcus faecium is a strain-related 
property, and that specific qualifications cannot be applied, therefore confirming the previous view 
that Enterococcus faecium should not be recommended for the QPS list.  
3.1.4.1. Update of antibiotic resistance aspects 
Enterococci show intrinsic resistance to several beta-lactams, low-levels of aminoglycosides, and 
trimethoprim-sulfamethoxazole. Additional intrinsic resistances to lincosamides and vancomycin are 
characteristics of specific enterococcal species (Leclerq and Courvalin, 2005; Murray, 1990). Mobile 
genetic determinants conferring resistance to different classes of antibiotics such as aminoglycosides 
[aph(3’)-III, and aac(6’) and aph(2’’) variants], ß-lactams (bla, pbp5), glycopeptides 
(vanA/B/D/E/G/L/M), phenicols (cat genes) tetracyclines (tetO/L/K/S/U), and to macrolides, 
lincosamides and streptogramins group (ermA/B/C/F/T, lnuB, vatB/D/E, msrA/C/D, lsaA, vgaB and 
mefA) have been observed in enterococci from different sources, including in food producing animals 
and food strains (Cocconcelli et al., 2004; Freitas et al., 2011; Hegstad et al., 2010; Hummel et al., 
2007; Rizzotti et al., 2005; Vignaroli et al., 2011).  
3.1.5. Lactobacillus species  
Since the 2010 update only few reports have been published concerning lactobacilli and clinical 
infections according to a PubMed search including ‘clinical infection’ and ´disease´. Additional 
search terms for lactobacilli are proposed:  ‘bacteremia’, ‘urinary tract infection’, ‘vaginal infection’, 
‘gingivitis’. 
One article from Turkey (Doğan and Baysal, 2010) detected a ‘Lactobacillus acidophilus or 
Lactobacillus jensenii’ strain in clinical specimen amongst other species in an immunocompromised 
patient. The clinical relevance of this isolate was not clear. In addition, the taxonomic identification 
was done with the API system and therefore no clear attribution to a taxonomic unit can be done. 
Several reports related to the well known association of lactobacilli with dental caries (Kneist et al., 
2010; Mathias and Simionato, 2011; Nagarajappa and Prasad, 2010). Kneist et al. (2010) found five 
species from carious dentine: Lactobacillus paracasei subsp. paracasei, Lactobacillus paracasei 
subsp. tolerans, Lactobacillus rhamnosus, Lactobacillus gasseri, and Lactobacillus alimentarius. 
They concluded that Lactobacillus rhamnosus and Lactobacillus paracasei subsp. paracasei occurred 
in all caries progression stages, whilst the other species were found only sporadically. There is a 
connection to endocarditis via caries which has been reported on several occasions earlier. There is 
also a possibility of lactic acid bacteria (LAB) being involved in endocarditis after dental surgery 
(Noti et al., 2009). Caries is a multifactorial disease, including bacteria from the oral cavity, eating 
and drinking habits (high sugar amounts) and insufficient oral and dental hygiene (Takahashi and 
Nyvad, 2011). Bacteria involved change through different stages of caries proliferation. In the primary 
phase mainly mutans streptococci are involved, whereas in secondary caries with lesions already 
present also lactobacilli, bifidobacteria and other LAB are involved (Ito et al., 2011; Takahashi and 
Nyvad, 2011). The conclusions of these studies are that without bacteria caries development is not 
possible. LAB, however, are present in caries stages with predisposing factors such as lesions and 
insufficient dental hygiene. The origin of those LAB (if deriving from food or as autochthonous oral 
microflora) has not been studied so far. In conclusion, LAB are not the initial cause of these diseases 
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and they are present in the human organism as commensal microflora. This has no relevance for the 
QPS recommendation. 
Doi et al. (2010) found Lactobacillus paracasei involved in a splenic abscess. But again as in 
previous similar case reports, the patient had an underlying disease and was immunocompromised. In 
a similar case with an immunocompromised patient (stem cell transplantation in a child) L. rhamnosus 
was found to be the causative agent for meningitis after recurrent episodes of bacteremia (Robin et al., 
2010). Russo et al. (2010) isolated a presumptive Lactobacillus casei strain from a bacteraemia case, 
where heavy consumption of dairy products was involved in the case history. However, no strains 
from dairy products (mainly cheese) were isolated and compared to the clinical strain. The 
identification was most probably misinterpreted, as only a 16S rDNA sequence analysis was done, 
which matched equally to Lactobacillus casei and Lactobacillus paracasei. Therefore Lactobacillus 
paracasei seems to be the correct identification given the distribution of species in humans and dairy 
products. Lactobacillus casei does not naturally occur in such environments. Lactobacillus rhamnosus 
can be associated with unexplained sustained bacteremia like in the TIPSS syndrome (tipsitis). This is 
a rare disease where Lactobacillus rhamnosus may be involved inter alia (Kochar et al., 2010).  
A research including ´urinary tract infection´ (UTI) revealed one review (Bernier et al., 2010) 
indicating a relatively higher risk for elderly women for urinary tract infections with L. delbrueckii. 
However, in general UTIs were reported seldom. The search term ´vaginal infection´ did not reveal 
more cases. 
In conclusion, there is no need to change the QPS recommendation of the previously recommended 
Lactobacillus species. 
3.1.5.1. Antimicrobial resistance aspects of lactic acid bacteria with regards to the qualification 
Intrinsic resistance could be shown mainly for aminoglycosides, quinolones, and glycopeptides 
(Hummel et al., 2007; Klein, 2011b). Acquired resistance genes are also known, especially the 
following: tet (including tet(M), tet(O), tet(S), tet(W), tet(K), and tet(L)); erm (including erm(A), 
erm(B) and erm(C)) (Hummel et al., 2007; Ammor et al., 2008). This is a non-comprehensive list. 
There is no new information that would require a modification in the qualification of the 
antimicrobial resistance. 
3.1.6. Lactococcus species 
New human case reports related to infections caused by Lactococcus lactis have been published 
recently, including a liver abscess and empyema in an imunocompetent adult (Kim et al., 2010) and a 
bacteremia in an infant suffering from necrotizing enterocolitis and receiving total parentheral 
nutrition via silicone catether (Glickman et al., 2010) and an endocarditis in a middle aged man 
complicated by intracerebral haemorrhage and leading to the death of the patient (Lin et al., 2010). In 
all these cases the causative microorganism was typed as Lactococcus lactis ssp. cremoris. In none of 
these cases a connection between consumption of raw milk or other dairy products (not even mother’s 
milk in the infant case) was identified. 
In a report from 2006 (Goyache et al., 2006) an infection by Lactococcus lactis ssp. lactis in lungs, 
liver and spleen of five birds (one mallard, three shovelers, and one coot) obtained from a mass die-
off of waterfowl in southwestern Spain has been described.  
While these recent findings do not warrant any reconsideration of the QPS status of Lactococcus 
lactis, some further study on both human and veterinary clinical isolates should be considered to find 
out any possible strain specific factors that might contribute to the pathogenicity.  
QPS 2011 update 
 
EFSA Journal 2011;9(12):2497 16
3.1.6.1. Antimicrobial resistance aspects with regards to the qualification 
According to the survey reported by Flórez et al. (2008) the lactococcal strains are generally 
susceptible to ampicillin, chloramphenicol, gentamicine and vancomycin, while intrinsically resistant 
to streptomycin. Occasional tetracycline resistances occur, associated, among others, with tet(S) and 
tet(M) genes. The findings do not contradict the MIC cut-off values proposed in the latest EFSA 
update of the antimicrobial resistance criteria (EFSA, 2008b). There is no new information that would 
require a modification in the qualification of the antimicrobial resistance. 
3.1.7. Leuconostoc species 
Three species of the genus Leuconostoc, Leuconostoc citreum, Leuconostoc mesenteroides and 
Leuconostoc lactis, were previously given a QPS recommendation. A fourth species, L. 
pseudomesenteroides, was considered unsuitable because of a limited body of knowledge on food and 
feed application and of its (rare) implication in opportunistic infections. Since 2010, a new report of 
three Leuconstoc infections in patients with malignancy, receiving intensive chemotherapy was 
published (Ishiyama et al., 2011).  In none of the three cases the species was identified. 
In conclusion, the QPS recommendations of the three Leuconostoc species are confirmed. 
3.1.7.1. Antimicrobial resistance aspects with regards to the qualification 
No new relevant information in the last year was published and the genus is covered by general 
section on lactic acid bacteria 3.1.1. There is no new information that would require a modification in 
the qualification of the antimicrobial resistance. 
3.1.8. Pediococcus species 
Bernabeu et al. (2011) report an association between Pediococcus species and liver abscess. The 
patient had a long history of Crohn´s disease and this is a very rare complication, according to the 
literature search of the authors. Therefore this is another example of rare infections by Pediococcus 
species in case of underlying severe diseases and immunocompromised patients. The QPS 
recommendations for the Pediococcus species are confirmed. 
3.1.8.1. Antimicrobial resistance aspects with regards to the qualification 
No new relevant information in the last year was published and the genus is covered by general 
section on lactic acid bacteria 3.1.1. There is no new information that would require a modification in 
the qualification of the antimicrobial resistance. 
3.1.9. Oenococcus oeni 
No case reports for clinical infections were found for Oenococcus oeni. The state of the previous 
EFSA opinion is still valid (EFSA, 2010). Therefore the QPS recommendation for Oenococcus oeni is 
maintained. 
3.1.9.1. Antimicrobial resistance aspects with regards to the qualification 
No new relevant information in the last year was published and the genus is covered by general 
section on lactic acid bacteria 3.1.1. There is no new information that would require a modification in 
the qualification of the antimicrobial resistance. 
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3.1.10. Dairy propionic acid bacteria 
A review revealed no new relevant information regarding human and animal infection which would 
require a reconsideration of the QPS recommendation of Propionibacterium freudenreichii and 
Propionibacterium acidopropionici. Therefore, they remain on the list of microorganisms 
recommended for QPS.  
3.1.10.1. Antimicrobial resistance in propionic acid bacteria with regards to the qualification 
The data on the antibiotic resistance patterns following a search in the PubMed database using 
keywords “Propionibacterium” and “Antibiotic resistance” does not indicate new relevant studies on 
dairy strains. One publication on the probiotic aspects of propionic acid bacteria (Suomalainen et al., 
2008), however, reports MICs of ampicillin, erythromycin, virginiamycin, gentamicin, streptomycin, 
kanamycin, tetracycline, chloramphenicol, vancomycin, narasin, bacitracin and linezolid for four 
specific Propionibacterium freudenreichii strains determined with the microdilution method. The 
values obtained are in good agreement with the proposed EFSA breakpoints, although a larger panel 
of strains should be screened in order to get a final confirmation of the EFSA breakpoints (EFSA, 
2008). 
There is no new information that would require a modification in the qualification of the 
antimicrobial resistance. 
3.1.11. Streptococcus thermophilus 
No reports of clinical infections related to Streptococcus thermophilus were identified in scientific 
literature since 2009. Therefore, the QPS recommendation for this species is maintained.  
3.1.11.1. Antimicrobial resistance of Streptococcus thermophilus with regards to the qualification 
Although few scientific information is still available on the Streptococcus thermophilus susceptibility 
to clinically relevant antibiotics, recent papers have shown the occasional presence of acquired 
resistance genes in this dairy bacterium. Streptococcus thermophilus strains which are phenotypically 
resistant to erythromycin, tetracycline and streptomycin have been reported by Tosi et al. (2007).  
The presence of acquired resistance genes, the erythromycin resistance determinant ermB and the 
tetracycline-resistance genes tet(S), tet(M), and tet(L) were detected in dairy strains of Streptococcus 
thermophilus (Rizzotti et al., 2009). These resistances are covered by the general qualification on 
antibiotic susceptibility. There is no new information that would require a modification in the 
qualification of the antimicrobial resistance. 
4. Gram-positive spore forming bacteria  
4.1.1. Bacillus species 
Concerning Bacillus species include in the QPS list, the following notifications were received since 
the last QPS Opinion (Appendix A):  
Bacillus amyloliquefaciens (Feed additive, enzyme production)  
Bacillus amyloliquefaciens subsp plantarum (Pesticides) 
Bacillus lentus (enzyme production) 
Bacillus megaterium (production of vitamin C) 
Bacillus pumilus (plant protection products) 
Bacillus subtilis (production vitamin B2 and enzyme production) 
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4.1.1.1. Update of the body of knowledge on safety concerns for Bacillus species on the QPS list 
A search on the Web of Science from 2010 to end of April 2011 with any of the key words “toxin, 
enterotoxin, lipopeptide, peptide, disease, infection, virulence, abortion, mastitis, bacteremia, 
poisoning, hepatitis, necrosis, necrotizing, pneumonia, endophthalmitis, gangrene, endocarditis, 
urinary tract, meningitis, encephalopathy, parodontitis”, combined with “Bacillus” (excluding cereus, 
anthracis and thuringiensis) retrieved 162 articles. This first search was completed by a second one 
with any of the key words “poultry, chicken, hen, broiler, turkey, fowl, piglet, pig, calf, calves, cattle, 
cow, fish, salmon” combined with “Bacillus” (excluding cereus, anthracis and thuringiensis) which 
found 64 articles. After examination of some of these articles, a third search combining “Bacillus” 
with “liver or hepatotoxic” identified 168 more articles.  
All these articles were screened. Most were not relevant. Few (Coutte et al., 2010; Liu et al., 2011; 
Tabbene et al., 2011; Raaijmakers et al., 2010; Thasana et al., 2010) concerned the antifungal or 
antimicrobial activities of Bacillus species and indicated that at least part of the activity was due to 
the peptidolipides (e.g., surfactin, fengicin, iturin) which are also suspected of being involved in the 
rare foodpoisoning cases caused by Bacillus species other than Bacillus cereus (EFSA, 2008a). Such 
Bacillus strains producing these lipopeptides would not meet the qualification “Absence of toxigenic 
activity” specified for Bacillus species in the QPS approach.  
One article (Lopez and Alippi, 2010) reports the characterisation of a Bacillus megaterium (a QPS 
Bacillus species) strain with the genes of the cytotoxin K and of the full enterotoxin HBL operon, two 
toxins involved in the virulence of the foodborne pathogen (and non QPS species) Bacillus cereus. 
The hemolysis pattern of this strain suggested the production of active HBL enterotoxin. The 
identification of the Bacillus megaterium strains, presented in Lopez and Alippi (2009), indicates that 
this was presumably not misidentified Bacillus cereus. The cytK and hbl genes were detected in the 
Bacillus megaterium strain by PCR. The sequence of the amplified PCR fragment would have been 
needed for a full confirmation. In any case, this strain of Bacillus megaterium would not meet the 
qualification “Absence of toxigenic activity” specified for Bacillus species in the QPS approach. 
Therefore, there is no need to change the QPS recommendation for Bacillus megaterium. 
An infective arthritis with Bacillus species was reported (Wiedermann et al., 2010). However the 
infection was the results of an arthroscopy and had presumably no link with the food chain. No 
change to the position of Bacillus species in the QPS list is needed. 
An acute hepatitis of a young adult was linked to the consumption of a dietary supplement (Krones et 
al., 2010) and the authors suspected toxigenic Bacillus isolated from the dietary supplement to have 
caused the disease. The two toxigenic strains were identified as one Bacillus cereus and one from the 
Bacillus subtilis group. The method used in this work to identify the strains (16S rDNA sequencing) 
is not able to distinguish all the strains within the Bacillus subtilis group. However, the species from 
the Bacillus subtilis group are on the QPS list, so it is possible that this hepatitis was at least partly 
caused by a Bacillus included in the QPS list. This paper refers to a previous report of several similar 
severe hepatotoxicity associated to the consumption of another dietary supplement contaminated with 
toxigenic Bacillus subtilis (Stickel et al., 2009). In the latter work, Bacillus cereus was not isolated 
from the dietary supplement and the B. subtilis strains were adequately identified using both 16S 
rDNA and gyrB sequences. In both works, the cytotoxins were detected in the supernatant of the 
strains grown in the laboratory, but not in the dietary supplements, indicating a likely infection of the 
patient by the Bacillus and production of the toxins in the patient, instead of an intoxination (i.e. 
production of the toxin in the food). However the works did not quantified the numbers of Bacillus 
present in the dietary supplements and Stickel et al. (2009) and Seff (2009) discuss a possible 
contribution of the supplement itself to the hepatotoxicity. In any case these two articles are the first 
reports of such severe disease possibly caused by ingestion of Bacillus subtilis related species or its 
toxins. These strains would be excluded from the QPS recommendation because of toxin formation 
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and would not meet the qualification “Absence of toxigenic activity” specified for Bacillus spp in the 
QPS approach. Therefore, there is no need to change the QPS recommendation for Bacillus subtilis.   
4.1.1.2. Antimicrobial resistance among QPS Bacillus species with regards to the qualification 
Few reports on antimicrobial resistance to relevant antibiotics among Bacillus species were published 
in the last year. Particularly of concern was the description in a swine Bacillus spp. of a plasmid 
encoding ermB and cfr gene (Dai et al., 2010). The cfr gene, previously described only in 
staphylococci, encode an RNA methyltransferase that affects an array of ribosomal antibiotics, 
including phenicols, oxazolidinone, lincosamides, pleuromutillins and streptogramin A (Long et al., 
2006; Dai et al., 2010). Moreover, a chromosomally located fexA gene, encoding resistance to 
phenicols and associated with a defective Tn558 transposition was also identified. Remarkably, 
plasmidic and transposon structures associated with these genes are similar to the ones observed in 
staphylococci, streptococci and enterococci being worrisome the possibility of its dissemination to 
pathogenic human and animal isolates (Dai et al., 2010).  
Tetracycline resistance genes tet(M) and tet(K) were previously described in some isolates of 
different environmental Bacillus species conferring resistance to tetracycline (Neela et al., 2009; 
Nikolakopoulou et al., 2008). Recently, a tetracyclin resistance gene tet(L) transferable to a Bacillus 
subtilis was observed in a Bacillus spp. strain isolated from a marine sponge Haliclona simulans 
(Phelan et al., 2011). 
In conclusion, the available data reinforces the possibility of emergence of important resistance genes 
in members of the Bacillus genus, confirming the importance of the qualification regarding 
antimicrobial resistance in the QPS approach. 
There is no new information that would require a modification in the qualification of the 
antimicrobial resistance. 
4.1.2. Clostridium species 
Clostridium butyricum was assessed this year for the first time. 
4.1.2.1. Taxonomy 
The genus Clostridium is composed by 202 different species that do not form a phylogenetically 
coherent group. Thus, Gram-positive, anaerobic rods forming endospore were originally assigned to 
this genus. A phylogenomic and comparative analyses made using data derived from sequenced 
clostridial genomes allowed to analyse the evolutionary relationships among species of Clostridia 
(Gupta and Gao, 2009). Clostridium butyricum is the type species of the genus. 
4.1.2.2. Toxigenic potential of Clostridium butyricum 
 
Strains of Clostridium butyricum are able to form botulinum neurotoxin type E, harbouring BoNT/E 
gene on a large plasmid (Hauser et al., 1992; Peck 2009). Toxigenic strains of this species were 
responsible for infantile botulism (Fenicia et al., 1999; Abe et al., 2008) and involved in foodborn 
intoxications. The gene coding for botulinum neurotoxin type E was detected only in a minority of 
Clostridium butyricum strains (Hauser et al., 1992). The body of knowledge on human and animal 
exposure to Clostridium butyricum is limited. 
 
This information supports the view that safety of Clostridium butyricum is a strain-related property, 
therefore Clostridium butyricum should not be recommended for the QPS list. 
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4.1.2.3. Antimicrobial resistance aspects  
A recent study reports the antibiotic susceptibility and genetic resistance determinants of Clostridium 
butyricum strains isolated from the faeces of infants (Ferraris et al., 2010). All the strains were 
susceptible to cefoxitin, imipenem, vancomycin, tigecycline, metronidazole, chloramphenicol and 
linezolid. Resistance was observed to clindamycin (100%), penicillin G, amoxicillin and piperacillin 
(15%), tetracycline (7.5%) and erythromycin (5%). The genetic basis of these resistances 
demonstrated that penicillin resistance was related to β-lactamase activity and that tetracycline 
resistance was due to tet(O) or tet(O/32/O) homologue genes. 
5. Gram-negative bacteria  
5.1.1. Ensifer species 
This species was assessed this year for the first time. 
5.1.1.1. Taxonomy 
The genus Ensifer is a valid taxonomic unit as are also the species Ensifer adhaerens and Ensifer 
fredii. However, the genus Sinorhizobium (Chen et al., 1988) and its Sinorhizobium morelense (Wang 
et al., 2002) are a later synonym of Ensifer adhaerens (Anonymous, 2008; Casida, 1982; Young, 
2003). Also the combination 'Sinorhizobium adhaerens' has been cited in the literature (Casida, 1982; 
Willems et al., 2003). Therefore, case reports including these no longer valid synonyms should also 
be considered. Ensifer fredii has also been described as Sinorhizobium fredii or was refered to as 
belonging to the genus Rhizobium as Rhizobium fredii. Therefore, also in case of Ensifer fredii those 
invalid taxonomic combinations should be considered for literature research. 
5.1.1.2. Safety assessment 
Ensifer adhaerens was first characterized as a predator of bacteria (Casida, 1982; Germida et al., 
1983). Species of the genus Ensifer are also legume symbionts forming root nodules and fixing 
nitrogen (Merabet et al., 2010; Rogel et al., 2001; Sawada et al., 2003). 
‘Ensifer’ was searched as key words in the topic of articles on the Web of Sciences, from 1975 to 
2011. 110 articles were found, all were screened. Ensifer adhaerens was first characterized as a 
predator of bacteria (Casida, 1982; Germida et al., 1983). No article mentioned human or animal 
safety concerns.  
‘Sinorhizobium’ (Title) was combined with toxin or enterotoxin or lipopeptid or peptid, disease or 
infection or virulence or abortion or mastitis or bacteremia or poisoning or hepatitis or necrosis or 
necrotizing or pneumonia or endophthalmitis or gangrene or endocarditis or urinary tract or 
meningitis or encephalopathy or parodontitis (topic) in the Web of Sciences from 1975 to 2011.  
108 articles were found. All were screened. No article mentioned a safety concern for human or 
animals. The reference to ‘infection’ referred to infection of plant tissues in the course of plant 
pathogens interactions for nodules formation. 
Ensifer fredii was also referred to as Rhizobium fredii. ‘Rhizobium fredii’ was used as search term for 
titles in the Web of Sciences, from 1975 to July 3rd 2011. 100 articles were retrieved. All were 
screened and dealt with symbiosis with plants. None reported safety concerns for human or animals. 
‘Rhizobium fredii’ (title) was combined with toxin or enterotoxin or lipopeptid or peptid, disease or 
infection or virulence or abortion or mastitis or bacteremia or poisoning or hepatitis or necrosis or 
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necrotizing or pneumonia or endophthalmitis or gangrene or endocarditis or "urinary tract" or 
meningitis or encephalopathy or parodontitis” (topic) in the Web of Sciences from 1975 to July 3rd 
2011. 62 articles were retrieved. All were screened and dealt with plant tissue infection for nodulating 
activity. None concern infection of human or animals. 
In conclusion, the body of knowledge of these two species concerns the ecology in the soil and the 
interaction with the plant root and does not give information on safety in the food and feed chain. 
Therefore, both species cannot be recommended for the QPS list. 
5.1.1.3. Antimicrobial resistance aspects 
In all papers screened, none of them mentioned antimicrobial resistance aspects. 
5.1.2. Ketogulonicigenium species 
This species was assessed this year for the first time. 
5.1.2.1. Taxonomic aspects 
So far ´Ketogulonicigenium vulgare´ has not been validly published published and therefore has from 
a taxonomic point of view no standing in nomenclature, despite of the notification in the notification 
list of the IJSEM (Anonymous, 2001; Urbance et al., 2001). Therefore ´Ketogulonicigenium vulgare´ 
is so far no officially acknowledged taxonomic unit. The reason is that at the time of publication, the 
type strain was not deposited in two publicly accessible service collections in different countries. The 
authors could submit evidence of the deposit of the type strain in additional collections to the List 
Editor of IJSEM before the next meeting of the Judicial Commission in Sapporo, Japan, in 2011, and 
the species can be considered as validly published afterwards. There are also spelling corrections, 
which should be considered for literature research: ´Ketogulonicigenium vulgare´ is sometimes 
referred to as ´Ketogulonicigenium vulgarum´, and the genus name has been corrected upon 
notificiation from ´Ketogulonigenium´ to ´Ketogulonicigenium´. These spelling differences should be 
therefore considered.  
5.1.2.2. Safety aspects 
Ketogulonicigenium vulgare can produce ascorbic acid from various substrates (Sugisawa et al. 
2005). 
The web of sciences was search for Ketogulonigenium or Ketogulonicigenium as topic, from 1975 to 
July 3rd 2011. 15 articles were found. All were screened and concerned vitamin C production. None 
reported safety concerns for human or animals, including antimicrobial resistance aspects. 
In conclusion, due to the little body of knowledge apart from this very specific usage, it cannot be 
recommended for the QPS list. 
5.1.2.3. Antimicrobial resistance aspects 
In all papers screened, none of them mentioned antimicrobial resistance aspects. 
6. Yeast 
The yeast species recommended for the QPS list are Debaryomyces hansenii, Hanseniaspora uvarum, 
Kluyveromyces lactis and Kluyveromyces marxianus, Saccharomyces bayanus, Saccharomyces 
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cerevisiae, Saccharomyces pastorianus, Schizosaccharomyces pombe and Xanthophyllomyces 
dendrorhous (imperfect form Phaffia rhodozyma), and for enzyme production purposes, 
Komagataella pastoris, Lindnera jadinii (formerly Pichia jadinii), Pichia angusta and 
Wickerhamomyces anomalus. During the review period, only few studies concerning safety aspects of 
these yeasts, including infections, disease, clinical significance, virulence and toxins were published.  
Saccharomyces cerevisiae which is recommended for the QPS list based on a long history of safe use 
has also been implicated in human infections (EFSA, 2007; EFSA, 2008a). A literature review for the 
preceeding year has not revealed any information that affected the recommendation for the QPS list 
(EFSA, 2009; 2010). During the last year, some manuscripts have been published concerning 
Saccharomyces cerevisiae. Some of them were included in the previous QPS report (EFSA, 2010). 
Recently, de Llanos et al. (2011) used two murine models (BALB/c and DBA/2N mice) to test 
clinical and commercial Saccharomyces cerevisiae strains by intravenous application. Considering the 
challenge conditions of this model it has limited significance for the recommendation of this species 
for the QPS list. There is a long history of safe use for Saccharomyces cerevisiae and the QPS 
recommendation is therefore maintained. 
The QPS recommendations of the last year can be confirmed for all other yeast species because no 
significant publications appeared during the last year related with clinical studies (EFSA, 2010). 
6.1.1. Xanthophyllomyces dendrorhous (imperfect form: Phaffia rhodozyma)  
Xanthophyllomyces dendrorhous is the only species of the genus Xanthophyllomyces and the 
anamorph or imperfect form is Phaffia rhodozyma. The present view that Xanthophyllomyces is 
limited to one species is due to lack of information on the genetic variability within the genus and the 
difficulty to examine cross strain mating studies, due to the primary cell/bud mode of sexual 
reproduction. The genetic variability has been explored in three regions of the rRNA gene (ITS, 
D1/D2 LSU and IGS1). D1/D2 analysis of 27 strains (Fell et al., 2007) demonstrated that all of the 
Xanthophyllomyces strains have identical sequences. However small variability has been observed in 
strain of Phaffia rhodozyma, due to this situation, both names are accepted in the the fifth edition of 
The Yeasts, a Taxonomic Study (Kurtzman et al., 2011). This species produces the high-value 
carotenoid astaxanthin. This pigment or appropriate precursors must be included in the animals’ diets 
to obtain their characteristic pigmentation.  
Since both forms have the same application and record of safe use, both forms are recommended for 
the QPS list. 
6.1.2. Trichosporon 
The Trichosporon mycotoxinivorans species belongs to the Trichosporon genus of basidiomycetous 
anamorphic yeasts. This species was first isolated in 1996 from the hindgut of the lower termite 
Mastotermes darwiniensis (Prillinger et al., 1996). The name of this species refers to its ability to 
detoxify mycotoxins such as ochratoxin and zearalenone. Some strains of this species were shown to 
detoxify ochratoxin A by cleavage of the phenylalanine moiety from the isocumarin derivate to 
ochratoxin α, a metabolite that has been described to be non-toxic or at least 500 times less toxic than 
ochratoxin A (Schatmayr et al., 2006). Trichosporon mycotoxinivorans is also able to metabolize 
Zearalenone in a metabolite (ZOM-1) that apparently shows no estrogenic activity anymore (Vekiru et 
al., 2010). Some recent results also support the potential of cell walls from Trichosporon 
mycotoxinivorans to bind enteropathogenic bacteria (E. coli spp and Salmonella spp) while having no 
adverse effect against beneficial or commensal bacteria (Ganner et al., 2010). However, a study by 
Hickey et al. (2009) described Trichosporon mycotoxinivorans as a novel respiratory human pathogen 
having a propensity for patients with cystic fibrosis and reported four cases of recognized 
Trichosporon mycotoxinivorans pneumonia. According to this last report and due to the limited body 
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of knowledge on human and animal exposure, Trichosporon mycotoxinivorans is ineligible for QPS 
status. 
6.1.3. Qualification for yeast regarding resistance to antimycotics 
With regards to the QPS update 2010, the section of antifungal drugs was updated. During the last 
year two major reviews about emerging opportunistic yeast infections and resistance patterns were 
published (Miceli et al., 2011; White and Hoot, 2011).  In the cases of QPS species only for 
Saccharomyces species and for Wickerhamomyces anomalus data are available. For both more than 
90% of isolates tested are sensitive to polyenes (amphotericin B formulations), echinocandins 
(caspofungin) and voriconazole and 60–89% of isolates tested for fluconazole. In the cases of 
Wickerhamomyces anomalus, 40–59% of isolates tested were reported sensitive to itraconazole. Very 
few data are available for drug efficacy but amphotericin B and voriconazole seem to be active in 
vitro against Saccharomyces cerevisiae whereas, fluconazole might be variable in activity (Miceli et 
al., 2011). It should be noted that some therapeutic antifungal agent can have severe secondary effects 
which limit their usage.  
 
Where Saccharomyces cerevisiae is the cause of a systemic infection it should be possible to cure the 
patients using available drugs. As the optimal growth temperature for this yeast is 30 °C and is not 
normally associated with infection the qualification is relevant to strains with an unusually high 
optimum growth temperature. For these strains susceptibility testing is recommended.  
Antifungal susceptibility testing is recommended for Wickerhamomyces anomalus and 
Saccharomyces cerevisiae strains able to grow at temperatures equal to or above 37° C. This 
qualification is only relevant if viable yeasts are intentionally introduced into the food chain. 
7. Filamentous fungi 
Filamentous fungi are important agents for intentional addition and use along the food chain. 
Therefore, even though no recommendation for the QPS list is anticipated in the near future, an 
updated knowledge on developments in this field and of the body of knowledge is considered 
essential in support of risk assessment that are carried out by EFSA. The body of knowledge on fungi 
in fields relevant for assessment of strains notified to EFSA is rapidly moving (e.g. methods for 
identification of strains, safety concerns for humans, nature and diversity of toxic compounds 
produced, conditions leading to toxin productions). The yearly update done in the QPS Opinions 
provides regular, useful and consistent information on fungal species of importance for EFSA (see 
section 1.2. of this opinion). 
The general body of knowledge on filamentous fungi has been updated in the present Opinion, 
considering in particular the progress and limitation in the taxonomy, in the knowledge of metabolic 
pathways and in the identification of the production of toxic compounds. New issues were considered, 
such as the resistance of fungi to therapeutic antifungal agents and the risks linked to the use of fungi 
as plant protection products. Where a species or genus is not mentioned in the specific sections in the 
text of the body of this opinion, a remark on the outcome of the 2011 review was included in the 
notification table (Appendix A). 
New notifications assessed since the 2010 QPS update (EFSA, 2010) were received for Ampelomyces 
quisqualis, Ashbya gossypii, Aspergillus aculeatus and Trichoderma asperellum. 
7.1.1. Ampelomyces 
This species was assessed this year for the first time. Ampelomyces quisqualis complex is reported as 
the most common and widespread pycnidial hyperparasite of the family Erysiphaceae, the cause of 
powdery mildew diseases (Kiss et al., 2004). Isolates from the genus Ampelomyces were among the 
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first mycoparasites to be studied in detail (first described in 1930) and were also the first fungi used 
as biocontrol agents of plant parasitic fungi. Since 1996, a commercial product called AQ-10 is 
available. This biofungicide is a pelleted formulation of conidia of Ampelomyces quisqualis isolate 
M-10. Since 1980 this product has been found to be tolerant with some fungicides, so it is 
recommended to be used in an integrated approach in combination with chemical pesticides. In 
studies of its mode of action (Kiss, 2003) Ampelomyces quisqualis is shown to colonize hyphae of 
powdery mildews to continue its growth internally, and it produces the pycnidia in the cells of the 
hyphae, conidiophores and immature cleistothecia of its fungal hosts. Thus, this intracellular 
mycoparasite suppresses the sporulation of the attacked powdery mildew mycelium and kills the 
parasitized cells.  There is still an ongoing debate on the taxonomy of the genus Ampelomyces. 
Although its genetic diversity has been investigated during the last five years and four distinct groups 
identified according to sequences divergence in the ITS rDNA and actin genes (Park et al., 2010), a 
single name is still applied to all pycnidial intracellular hyperparasites of powdery mildew (inducing a 
high possibility of confusion with isolates of Phoma glomerata, according to Sullivan and White 
(2000)). Recently, it has been reported that the host specificity of Ampelomyces isolates was not so 
pronounced since some isolates were shown to be able to infect powdery mildew species they were 
unlikely to have encountered in nature (Kiss et al., 2011).  This raises the risk of non-target effects 
with potential ecological impacts associated with the release of this biological agent (Brimner and 
Boland, 2003). According to the two toxicological reports included in the North America pesticide 
database (PAN) and the European pesticide properties database (PPDB), there is no evidence of 
adverse effects in animal and human exposed to A.  quisqualis isolate M-10 and no indication of 
hypersensitivity was reported. There have been no reported cases of adverse reactions associated with 
the production of the biological fungicide.   
However, despite their apparent safe use as biocontrol agents, it has not been possible through 
extensive literature searches to verify a general absence of biological active secondary metabolites 
from Ampelomyces quisqualis isolates.  Taxonomy of this genus requires also to be elucidated. Thus, 
this species cannot be proposed for QPS status. 
7.1.2. Ashbya 
This species was assessed this year for the first time. Ashbya gossypii is a filamentous ascomycete 
fungus with the smallest genome known for a free-living eukaryote yet characterized. With its close 
ties to yeast and a facility of genetic manipulation, Ashbya gossypii is well suited as a model to 
elucidate the regulatory networks that govern the functional differences between filamentous growth 
and yeast growth. This explains the numerous publications (more than 150, according to a Web of 
Science search) that have been devoted to this species during the last ten years. The genome of 
Ashbya gossypii has been sequenced and annoted in 2004, 90 % of the genes present in the genomes 
of Ashbya gossypii and Saccharomyces cerevisiae were found to be orthologous and syntenic 
(Dietrich et al., 2004). Ashbya gossypii is also a riboflavin-producing filamentous fungus that converts 
vegetable oil to vitamin B2 in a "one-step reaction".  Potential to produce riboflavin is a common trait 
in this fungal species with the occurrence of high and low-producing strains. Together with Candida 
famata and Bacillus subtilis, Ashbya gossypii belongs to the three most common microorganisms that 
are currently in use for industrial riboflavin production (Stahmann et al., 2000). The productivity and 
selectivity of this microorganism have been improved significantly over the years, with the 
identification of overproducing mutants or the use of genetically modified strains. An extensive 
literature search did not reveal any information on toxic metabolites from this species. However, in 
the future, the knowledge of Ashbya gossypii should allow identifying genes cluster involved in the 
biosynthesis of toxic secondary metabolites.  
The body of knowledge concerning the capacity of Ashbya gossypii to produce biological active 
secondary metabolites remains limited and this species cannot be proposed for QPS status.  
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7.1.3. Aspergillus species 
Among the quite many new papers on Aspergillus species there are no relevant reports on the lack of 
toxicity or toxin production. Most reports on Aspergillus niger and Aspergillus oryzae deal with the 
genetic regulation of enzyme production or the industrial production of metabolites. There are also 
some reports on food spoilage and mycotoxins contamination by Aspergillus niger.  
 
7.1.3.1. Aspergillus aculeatus 
This species was assessed this year for the first time. The notified Aspergillus aculeatus is a tropical 
species within the black aspergilli complex and has been reported to produce the mycotoxins 
secalonic acid D and F (EFSA, 2010; Samson et al., 2007) and is therefore ineligible for the QPS list.  
7.1.4. Beauveria bassiana 
Since the beginning of 2010, a significant number of reports (close to 300) have been published 
concerning Beauveria bassiana according to a PubMed and Web of Science search. Actually, 
Beauveria bassiana is a well-characterized entomopathogenic fungus with a high host range and a 
high potential in insect pest control. Several strains of Beauveria bassiana have been licensed for 
commercial use against whiteflies, aphids, thrips and numerous other insects or arthropod pests. Like 
any microorganism, Beauveria bassiana has the potential to act as an opportunistic pathogen, but as 
the literature studies confirms, Beauveria bassiana infections are extremely rare events. No new case 
of Beauveria bassiana-mediated tissue infection has been reported since the beginning of 2010.  
However, a recent report (Pagiotti et al., 2010) has demonstrated the occurrence of Beauveria 
bassania in a clinical environment. The exposure and health risk linked to the aerosolization of fungal 
pest control agents including Beauveria bassania has also recently been underlined (Madsen, 2011), 
according to the previous report of Westwood et al. (2005) on the allergens detained by Beauveria 
bassania.  
Due to recognised, though limited human infection and its allergenic potential, Beauveria bassania is 
ineligible for the 2011 QPS list.  
7.1.5. Beauveria brongniartii 
During 2010 and the five first months of 2011, twelve reports dealing with Beauveria brongniartii 
have been identified through a PubMed and Web of Science survey. The majority of these focuse on 
the entomopathogenic potential of this fungal species. New data concerning the phylogeny and 
systematics of the genus Beauveria have also been published, with the identification of six new 
species in addition to Beauveria brongniartii and Beauveria bassiana (Rehner et al., 2011).  In two 
manuscripts, the environmental risk posed by the use of Beauveria brongniartii as a biological control 
agent was considered; the low persistence in soils of this entomopathogenic fungus was confirmed 
(Laengle and Strasser, 2010; Scheepmaker and Butt, 2010).  
No new data demonstrate the lack of toxicity associated with Beauveria brongniartii or clarify the 
toxicity of oosporein, an antifungal peptide produced by this species. Therefore, Beauveria 
brongniartii is still ineligible for QPS status.  
7.1.6. Blakeslea 
The search for new information on the genus Blakeslea did not retrieve any new relevant data on 
toxicity or toxins (EFSA, 2010). All papers were on production of lycopene from Blakeslea species. 
In light of this limited information Blakeslea trispora is still not recommended for QPS. 
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7.1.7. Coniothyrium minitans 
Twenty-five reports concerning Coniothyrium minitans have been published since the beginning of 
2010, according to a bibliographic survey based on PubMed and Web of Science as databases. The 
major part of these reports describes data that support the efficacy of Coniothyrium minitans for 
biological control of Sclerotinia diseases but also its potential for chitinase production and oxalic acid 
degradation. No new data certifying the lack of biological active secondary metabolites produced by 
this species has been retrieved and Coniothyrium minitans remains ineligible for QPS status.  
7.1.8. Duddingtonia flagrans 
Twenty-three reports on Duddingtonia flagrans have been published since the beginning of 2010 
(using PubMed and Web of Science as bibliographic databases). Most of them deal with the nematode 
predatory activity of this species and illustrate the fact that Duddingtonia flagrans stands out as the 
most promising agent for the control of gastrointestinal nematodiasis in domestic animals. The 
environmental impact of   Duddingtonia flagrans application was investigated in the study of Paraud 
et al. (2011) that led to the conclusion of an insignificant effect on the free-living soil nematodes. The 
recent search did however not retrieve any new relevant data on the toxicity of metabolites from this 
organism and Duddingtonia flagrans remains ineligible for QPS status. 
7.1.9. Fusarium species 
More of 1500 papers devoted to Fusarium have been retrieved in the time frame of search 2010-2011, 
using the Web of Science database. This high publishing activity illustrates the significant interest 
that phytopathogenic and mycotoxinogenic fungal strains of this genus still bring up.  
7.1.9.1. Taxonomy 
The set of available Fusarium species–specific primers has been largely enriched since the beginning 
of 2010 and the relevance of real-time PCR assay for predicting cereals contamination illustrated 
(Sampietro et al., 2010; Pasquali et al., 2010). A recent paper published by Park et al. (2011) 
describes the state of progress reached by the integrated platforms that the Fusarium community has 
built in order to facilitate strain identification, phylogenetics studies (Fusarium identification database 
or Fusarium-ID), comparative genomics (Fusarium Comparative Genomics Platform or FCGP) and 
knowledge sharing (Fusarium community platform or FCP). Fusarium-ID 
(http://isolate.fusariumdb.org/) archives more than 5500 markers (a number that continuously 
increases), representing over than 200 species. Sequences at three loci (EF-1α, RNA polymerase 
RPB1 and RPB2) are available for all the described phylogenetic species that can serve as relevant 
tools to help identify new isolates.   
7.1.9.2. Biosynthetic pathways of Fusarium mycotoxins and their regulation 
Although more than 300 papers dealing with Fusarium mycotoxins have been published since the 
beginning of 2010 (according to a Web of Science search), no significant progress has been made in 
elucidating the regulatory mechanisms that induce or repress mycotoxins production. The most 
relevant data concern the identification of factors that, in planta, are likely to modulate toxins 
accumulation, such as polyamines for trichothecenes (Gardiner et al., 2010) and oxylipins for 
fumonisins and aflatoxins (Christensen and Kolomiets, 2011). A recent paper describes also cobalt 
chloride as an efficient enhancer of in vitro trichothecenes production, and as a useful tool to 
investigate regulatory mechanisms (Tsuyuki et al., 2011). 
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7.1.9.3. Emerging Fusarium toxins 
Enniatins, beauvericin, moniformin and fusaproliferin have been the subject of several papers 
(approximately 15 for each toxin) since the beginning of 2010 (according to a Web of Science 
search). Definition of ‘Taqman’ assays to quantify the producers, elucidation of the biosynthetic 
pathway and required genes, investigation of their toxic effects are the main topics developed in these 
papers. There is also an ongoing debate on the question of a higher prevalence of these emerging 
toxins linked to climate–change effects (Magan et al., 2011). 
7.1.10. Gliocladium catenulatum  
The current name in use for Gliocladium catenulatum is Clonostachys rosea f. catenulata and the 
taxonomic relationship as well as nomenclature is described in detail (EFSA, 2009). Bertinetti et al. 
(2010) report the production of a new antimicrobial compound, which is active against the honey bee 
pathogen Paenibacillus larvae, but showed no activity against Bacillus subtilis, Staphylococcus 
aureus and Escherichia coli (Bertinetti et al., 2010). No information on lack of toxins or toxicity 
against mammals is reported, therefore this species cannot be proposed for the QPS list. 
7.1.11. Lecanicillium muscarium 
All reports from a Web of Science search deal with the pathogenicity against insects. No new data on 
toxins or safety has been published, therefore this species cannot be proposed for the QPS list. 
7.1.12. Metarhizum anisopliae  
Many of the nearly 300 reports on Metarhizum anisopliae retrieved by a search in Web of Science 
deal with the production of metabolites and genetic and physiological regulation of the metabolism, as 
well as the toxicity towards insects. However, a recent report demonstrates cytotoxic effects of 
conidia in the lungs of mice (Anand and Tiwary, 2010) and a case of corneal ulcer in a child (Motley 
et al., 2011). A recent review of the toxins of Metarhizium anisopliae does not bring forward any 
general lack of toxicity (Schrank and Vainstein, 2010). Therefore Metarhizum anisopliae cannot be 
proposed for the QPS list.  
7.1.13. Paecilomyces lilacinus 
Since the beginning of 2010, according to a PubMed and Web of Science search, more than 70 
publications dealing with Paecilomyces lilacinus have been published. Among these, several reports 
support the potential of this species as an agent for the control of plant-parasitic nematodes. In 10 
papers, human and animal invasive infection events linked to Paecilomyces lilacinus (or related 
species) are described: four cases of Paecilomyces keratitis (Yildiz et al., 2010; Pei-Chen et al., 
2010), one of invasive fungal rhinitis (Ciecko et al., 2010), a case of dog dermatomycosis (Han et al., 
2010) and one of fungal endophtalmitis in an immunocompetent patient (Anita et al., 2011). 
According to two supplementary papers (Rosmaninho et al., 2010; Houbraken et al., 2010), 
Paecilomyces lilacinus is considered as one of the most frequently encountered emerging causative 
agents leading to opportunistic infection, especially in immunocompromised and transplant patients. 
Based on this, Paecilomyces lilacinus cannot be proposed for the QPS list. 
7.1.14. Penicillium species 
For the Penicillium species, Penicillium camemberti, Penicillium chrysogenum, Penicillium 
funiculosum, Penicillium nalgiovense and Penicillium roqueforti, no new information on the lack of 
toxicity or toxins have been retrieved. The reports deal with production of the specific products or 
food spoilage problems.  
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7.1.15. Phlebiopsis gigantea 
The recent search in Web of Science did not reveal any new information of the general lack of 
toxicity of Phlebiopsis gigantea. The knowledge concerning the capacity of Phlebiopsis gigantea to 
produce biological active secondary metabolites remains therefore insufficient and this species cannot 
be proposed for the QPS list.  
7.1.16. Pseudozyma flocculosa 
The recent search for new information on metabolites or (lack of) toxicity did not retrieve any new 
relevant data for this organism. The body of knowledge is insufficient to propose Pseudozyma 
flocculosa for the QPS list.  
7.1.17. Pythium oligandrum 
Seven reports have focused on Pythium oligandrum since the beginning of 2010, according to a 
bibliographic survey using PubMed and Web of Science as databases. These reports support the 
ability of this hyperparasite to colonize other pathogenic fungi in and around seeds and the 
rhizosphere of treated plants. One report clarifies the mechanisms by which Pythium oligandrum is 
also able to enhance plant defence reactions (Masunaka et al., 2010). When the key word pythiosis 
was used, 17 reports, all associated with the Pythium insidiosum species, were retrieved. 
No new data demonstrated the lack of toxicological or pathogenic effects of Pythium oligandrum in 
mammals. Therefore, Pythium oligandrum is still ineligible for QPS status. 
7.1.18. Trichoderma species 
More than 900 papers have been published since the beginning of 2010 (according to a Web of 
Science search).  The most frequently reported results concern the use of some strains belonging to 
this genus for enzymes production, mainly enzymes involved in plant cell wall degradation.  
7.1.18.1. Taxonomy 
The taxonomy of Trichoderma has been improved by a handful of papers and monographs that 
clarifies the species delimitation in some sections of this genus. The new taxonomic schemes do not 
have any impact on taxonomic designations of species notified to EFSA.  
7.1.18.2. Trichoderma asperellum 
This species was assessed this year for the first time. Trichoderma asperellum strains are commonly 
isolated from soil and decomposing matter, occurrence of marine strains is also reported. According 
to a Web of Science and PubMed searches, the major part of the more recently published reports that 
deals with Trichoderma asperellum illustrates its efficiency as a mycoparasitic biocontrol agent. 
Trichoderma asperellum is described as an antagonist of many soil borne fungal plant pathogens such 
as Sclerotinia spp., Thielaviopsis paradoxa (Wijesinghe et al., 2010), Fusarium oxysporum and of 
root-knot nematodes (Affokpon et al., 2011). The use of Trichoderma asperellum as a method of 
bioremediation for soil, sediment or water contaminated with heavy metals has also been investigated 
and the uptake capacity of Trichoderma asperellum for arsenic was illustrated (Su et al., 2010). In one 
of the retrieved report, the production of neurotoxic metabolites by marine-derived strains of 
Trichoderma asperellum was demonstrated, the structures of six peptaibols called asperelines A-F 
were elucidated (Ren et al., 2009).  
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Considering the capacity detained by some strains of Trichoderma asperellum to produce biological 
active compounds, each strain should be investigated in detail, which makes Trichoderma asperellum 
ineligible for QPS status.   
7.1.18.3. Trichoderma longibrachiatum  
This species was assessed this year because a notification relating to enzyme production was received. 
Trichoderma longibrachiatum is one of the most studied filamentous fungi for its potential to produce 
plant cell wall-degrading enzymes (xylanase, cellulase, glucanase) with a high diversity of industrial 
applications:  pulp and paper industry, green chemistry, biofuel, food and feed industry. Among the 
23 reports devoted to Trichoderma longibrachiatum that have been published since the beginning of 
2010 (PubMed and Web of Science searches), half of them concern the efficient use of Trichoderma 
longibrachiatum for enzyme production. Trichoderma longibrachiatum is a very common fungus in 
environmental samples from all over the world with also the occurrence of marine strains. Production 
of peptaibols such as longibrachin-A-I by these marine-related strains is well documented (Mohamed-
Benkada et al., 2006). These toxic metabolites, that exhibit neurotoxicity by forming pores in 
neuronal membranes, were also recently demonstrated to enhance the toxicity of domoic acid, a 
neurotoxic phycotoxin (Ruiz et al., 2010). Moreover, Trichoderma longibrachiatum shows increasing 
medical importance as an opportunistic human pathogen particularly in immunocompromised and 
immunosuppressed patients.  Trichoderma longibrachiatum is described as the causal agent in the 
majority of reported Trichoderma mycoses. One of the more recently reported clinical case related to 
Trichoderma longibrachiatum was the case of an infection in a renal transplant recipient in Tunisia 
(Trabelsi et al., 2010). According to the previous comments, Trichoderma longibrachiatum cannot be 
eligible for QPS status. 
7.1.18.4. Trichoderma viride 
Trichoderma viride was re-assessed this year because a notification for enzyme production was 
received. Trichoderma viride is a well-known cellulose-degrading fungus and a well studied fungus 
for its ability to produce large amounts of cellulolytic enzymes. However, according to Cvetnic and 
Pepeljnjak (1997), some strains of Trichoderma viride have the ability to produce a highly toxic 
metabolite, the diacetooxyscirpenol. There is no solid proof that their observation is true. Their strains 
were unnumbered and have not been kept in a collection for re-evaluation and their chemical 
detection is by TLC which is highly insufficient for the trichothecenes such as diacetoxyscirpenol. A 
clarification of production of trichothecenes by Trichoderma species was published later (Nielsen et 
al., 2005) where it was demonstrated that the trichothecene producer should be named Trichoderma 
brevicompactum. Later, another new species, Trichoderma arundinaceum, was also found to produce 
trichothecenes (Degenkolb et al., 2008). 
As already concluded in previous EFSA Opinions (EFSA, 2009; 2010), Trichoderma viride cannot be 
granted QPS status as this and other Trichoderma species do produce the highly biological active 
peptaibols, which are small peptides (15-20 amino acids) containing α-aminoisobutyric acid.  
According to this potentiality to produce mycotoxins, Trichoderma viride cannot be recommended for 
the QPS list. 
7.1.19. Verticillium alboatrum 
A bibliographic survey using PubMed and Web of Science as databases indicates that 26 reports have 
been recently devoted to Verticillium alboatrum (since the beginning of 2010). The pathogenicity of 
this species in relation to wilt diseases of vegetable crops was the focus of these 26 reports. No new 
data have been published since the beginning of 2010 clarifying the toxicity of alboatrin and VD-
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toxins, two phytotoxins produced by Verticillium albo-atrum. The body of knowledge remains 
therefore very limited, and this species cannot be proposed for the QPS list.   
7.1.20. Conclusions on filamentous fungi 
In the 2010 QPS opinion, it was concluded that filamentous fungi cannot be proposed for inclusion on 
the QPS list owing to three main rationales: the frequent occurrence of inaccuracies and 
inconsistencies in fungal species identification, the insufficient knowledge concerning the regulation 
mechanisms underlying the production of fungal metabolites and the poor knowledge concerning the 
toxic impact of fungal secondary metabolites. Although numerous data, published since the 2010 QPS 
opinion, have contributed to partially fulfil these gaps of knowledge, too many unknowns remain in 
2011 to allow a filamentous fungus to be qualified as QPS.  
The extensive literature search that has been performed to establish this 2011 QPS opinion has 
actually underlined the tremendous progress in filamentous fungus knowledge recently achieved but 
has also illustrated an increased activity in the discovery of new mycotoxins, designed as emerging 
mycotoxins.  
7.2. Viruses used for plant protection 
7.2.1. Potyviridae 
Viruses belonging to the family Potyviridae are used for cross protection purposes, i.e. the application 
of mild strains of a virus protects the crop against strains of the virus giving severe symptoms. Their 
potential effects on animals and/or humans, when applied to food or feed, were reviewed and 
assessed,  and the results were published in the EFSA Opinion on QPS 2009 (EFSA, 2009) and 2010 
(EFSA, 2010). It was concluded that there was no scientific or other evidence that potyviruses have 
any negative effect on animals and humans to date. In addition, the familiarity principle was taken 
into consideration as well in that these viruses have been part of the food and feed for animals and 
humans since plant material was part of the food package. Hence it was agreed that the family 
Potyviridae is the highest taxonomic unit, which should receive QPS status. Since this last major 
review, no new information which would compromise the conclusion drawn in 2010 has appeared. 
Furthermore, evidence was found (Kuiper et al., 2001) that the major products of potyviruses that are 
used in cross protection (zucchini yellows mosaic virus) were specifically evaluated for their possible 
toxic effect on animals when expressed in transgenic plants. The sequences of these products, the coat 
proteins of watermelon mosaic virus 2 and zucchini yellows mosaic virus, were compared to 
databases of known proteinaceous toxins, but none of these showed any homology to potential known 
mammalian protein toxins (Health Canada, 1999). In conclusion, viruses belonging to the Potyviridae 
family should remanin to receive QPS status. 
7.2.2. Baculoviridae 
Viruses belonging to the family Baculoviridae and their potential effects on animals and humans, 
when applied to food or feed, were extensively reviewed and the results were published in the EFSA 
Opinion on QPS 2009 (EFSA, 2009) and 2010 (EFSA, 2010). It was concluded that there was no 
scientific or other evidence that baculoviruses have any negative effect on animals and humans to date 
when used appropriately as a biocontrol agent. In addition the familiarity principle was taken into 
consideration as well in that these viruses have been extensively used for over five decades as 
biocontrol agents of insect pests without any report describing a negative effect on humans or 
animals. Furthermore, baculoviruses frequently appear in nature as disease agent of insect caterpillar, 
without a negative report on human or animal health. The OECD already concluded that 
baculoviruses were safe to use for products intended for human consumption (Anonymus, 2002). 
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Hence it was agreed that the family Baculoviridae is the highest taxonomic unit should receive QPS 
status in the registration process (EFSA 2009; EFSA 2010).  
Since the last major review, no new information which would compromise the conclusion drawn in 
2009 and 2010 has appeared. Further support for the safety of baculoviruses is taken from the fact that 
a number of baculovirus-derived products (recombinant proteins) have been registered and reached 
the market, such as vaccines against cervical cancer (Harper, 2009; Szarewski, 2010), porcine 
circovirus (Fort et al., 2009) and immunotherapeutics for prostate cancer (Kantoff et al., 2010). 
A matter of contention could be the observation that the budded virus (BV) phenotype of 
baculoviruses, that is responsible for the systemic infection of insect larvae, is able to infect 
mammalian cells and tissues to serve as a gene delivery vehicle for gene therapy (Hu, 2008; Rivera-
Gonzalez et al., 2011). BV infection and replication is very specific for insects only. The infection 
(entry) by the BV form of baculoviruses of mammalian cells is very artificial and will never happen in 
natural situations. In addition, replication of baculovirus in mammalian cells has never been shown.  
Furthermore, the in vivo complement system in mammalian blood eliminates the BV form of the virus 
as soon as it enters, but does not block gene delivery (Hofmann and Strauss, 1998). The baculovirus 
phenotype present in the baculovirus capsule, as it is used for biocontrol, cannot infect mammalian 
cells; moreover the baculovirus capsules will pass the digestive system unaffected.  
When appropriately used, baculovirus in conjunction with food and feed will impose no harm on 
animal or human health. 
Apart from the intrinsic biological features of baculoviruses and their inherent safety for humans and 
other vertebrates, a point of attention to note is the fact that these viruses have to be produced in 
animals (insects) and have to be formulated to stick to plant material and to protect the virus against 
UV damage. Microbial contaminants, allergenicity and toxicity of additives are among the agents, 
which could affect human and animal health. This concerns the formulation and does not contradict 
the recommendation to include the Baculoviridae on the QPS list. Regulation on the microbiological 
contaminants in baculovirus preparations is in place as part of the registration requirements (Rochon 
et al., 2009).  
QPS 2011 update 
 
EFSA Journal 2011;9(12):2497 32
Table 1:  The 2011 updated list of QPS recommended biological agents 
Gram-Positive Non-Sporulating Bacteria 




Bifidobacterium bifidum  
Bifidobacterium breve 
Bifidobacterium longum  
Corynebacterium 
glutamicum** 
  QPS recommendation only 
when the species is used 
for amino acid production. 
Lactobacillus acidophilus  
Lactobacillus 
amylolyticus  
Lactobacillus amylovorus  
Lactobacillus 
alimentarius  
Lactobacillus aviaries  
Lactobacillus brevis  
Lactobacillus buchneri  




Lactobacillus crispatus  
Lactobacillus curvatus  
Lactobacillus delbrueckii 
Lactobacillus farciminis  
Lactobacillus fermentum  
Lactobacillus gallinarum  
Lactobacillus gasseri  
Lactobacillus helveticus  
Lactobacillus hilgardii  
Lactobacillus johnsonii  
Lactobacillus 
kefiranofaciens  
Lactobacillus kefiri  
Lactobacillus mucosae  
Lactobacillus panis 
Lactobacillus collinoides 
Lactobacillus paracasei  
Lactobacillus 
paraplantarum  
Lactobacillus pentosus  
Lactobacillus plantarum  
Lactobacillus pontis  
Lactobacillus reuteri  
Lactobacillus rhamnosus  
Lactobacillus sakei  





Lactococcus lactis    
Leuconostoc citreum Leuconostoc lactis Leuconostoc 
mesenteroides 
 
 Oenococcus oeni   








   
Bacillus 
Species  Qualifications*  
Bacillus 
amyloliquefaciens  
Bacillus atrophaeus  
Bacillus clausii  
Bacillus coagulans  
Bacillus fusiformis 
Bacillus lentus  
Bacillus licheniformis  
Bacillus megaterium  
Bacillus mojavensis 
Bacillus pumilus  
Bacillus subtilis  
Bacillus vallismortis  
Geobacillus 
stearothermophilus 
Absence of toxigenic 
activity. 
* Generic qualification for all QPS bacterial taxonomic units: the strains should not harbour any acquired antimicrobial 
resistance genes to clinically relevant antibiotics. 
**  Brevibacterium lactofermentum is a synonym of Corynebacterium glutamicum  
*** The previously described species “Lactobacillus zeae” has been included in the species Lactobacillus casei 
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Table 1 Continued: The 2011 updated list of biological agents recommended for QPS 
Yeasts14 
Species  Qualifications  
Debaryomyces hansenii    
Hanseniaspora uvarum    
Kluyveromyces lactis Kluyveromyces marxianus   
Komagataella pastoris 
Lindnera jadinii  
Pichia angusta 
  QPS applies only when the 











   
Wickerhamomyces 
anomalus**** 
  QPS applies only when the 




form Phaffia rhodozyma)  
   
Virus    
Family    
Potyviridae Baculoviridae   
    
****Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are added 
to the food or feed chain. In the case of Saccharomyces cerevisiae this qualification applies for yeast strains able to 
grow above 37 °C.  
†  S. cerevisiae, subtype boulardii is contraindicated for patients of fragile health, as well as for patients with a central 


























14 Yeast synonyms commonly used in the feed/food industry 
 Wickerhamomyces anomalus: synonym Hansenula anomala, Pichia anomola, Saccharomyces anomalus 
 Lindnera jadinii: anamorph Candida utilis; synonyms Pichia jadinii, Hansenula jadinii, Torulopsis utilis 
 Saccharomyces cerevisiae synonym S. boulardii 
 Saccharomyces pastorianus: synonym of Saccharomyces carlsbergensis 
  Komagataella pastoris: synonym Pichia pastoris 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Answer to the terms of reference (ToR): 
ToR1: Preparation of an update of the list of biological agents notified to EFSA for safety 
assessment. This should be a starting point for identifying new taxonomic units for review under the 
QPS assessment. Only those taxonomic units relevant to current legal requirements in the context of 
notification to EFSA for intentional use in feed and/or food or as sources of food and feed additives, 
enzymes and plant protection products shall be included. The list was completed with the 
notifications received where applicable by EFSA Panels and Units since the last review.  
ToR2: Annual review of the list of biological agents recommended for the QPS list. Where 
appropriate new taxonomic units should be assessed for their suitability for an inclusion in the QPS 
list, and taxonomic units previously assessed should be reviewed where new information has become 
available. The information provided in the previous opinion should be updated where appropriate. 
All taxonomic units previously recommended for the QPS list were confirmed. The notifications were 
assessed and no new recommendations for the QPS list were made.  
An assessment of three new bacterial species (Ensifer adhaerens and Ensifer fredii, 
Ketogulonicigenium vulgare, Clostridium butyricum), a new yeast species (Trichosporon 
mycotoxinivorans) and several additional fungi species (Ampelomyces quisqualis, Ashbya gossypii, 
Aspergillus aculeatus, Trichoderma asperellum, Trichoderma longibrachiatum for enzyme 
production, Trichoderma viride for enzyme production) was performed but these species were not 
included on the QPS list.  
Phaffia rhodozyma the imperfect form of Xanthophyllomyces dendrorhous was included on the QPS 
recommended list. In accordance with the most recent taxonomic revision of yeasts, Pichia jadinii 
was changed to Lindnera jadinii. 
The information of the previous opinion was updated for the taxonomic units on the QPS list.  
ToR3 and 4: Review and update of knowledge concerning antimicrobial resistance in taxonomic units 
recommended for the QPS list. Review of the qualifications for taxonomic units included on the QPS 
recommended list. 
The information of the previous opinion was updated for bacteria and the qualification on 
antimicrobial resistance was confirmed.  
For the yeast the knowledge on antimycotic resistance was updated and the qualification ‘on absence 
of resistance to antimycotics used for medical treatment of yeast infections’ was complemented by the 
sentence ‘in the case of Saccharomyces cerevisiae this qualification applies for yeast strains able to 
grow above 37 °C’. This qualification is only relevant if viable yeasts are intentionally introduced into 
the food chain and it was restricted to those yeast species for which information on antifungal 
susceptibility exists. 
ToR5: Review of the body of knowledge for filamentous fungi and enterococci. 
The knowledge of filamentous fungi notified for EFSA was updated. Although numerous data, 
published since the 2010 QPS opinion, have contributed to partially fulfil gaps of knowledge, too 
many unknowns remain in 2011 to allow a filamentous fungus to be qualified as QPS.  
Enterococci cannot be considered for the QPS list based on the current scientific knowledge. 
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RECOMMENDATIONS 
While recent findings do not warrant any reconsideration of the QPS status of lactic acid bacteria 
(LAB) and Bacillus species, further studies on both human and veterinary clinical isolates particularly 
from cases where there have been no predisposing factors, should be considered to find out any 
specific factors that might contribute to the pathogenicity.  
More data on minimum inhibitory concentrations (MIC) for therapeutic antimicrobials and guidelines 
for the interpretation are needed in general for all bacteria used for food and feed purposes. 
More information on the antifungal susceptibility of yeasts frequently introduced into the food and 
feed chain is needed. 
Concerning fungi, the same recommendations as those issued from the 2010 QPS opinion remain 
valuable. Progresses have to be achieved to attain three main objectives:  
(i)  the definition and use of standardized methods to allow a correct identification of fungal 
species  
(ii)  an accurate establishment of the metabolic profile for each considered species and an 
increased knowledge of the factors controlling the production of fungal toxic metabolites 
(iii)  an increased knowledge of the toxicological impact of fungal secondary metabolites.  
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APPENDIX 
A.  MICROBIAL SPECIES FROM PREVIOUS NOTIFICATIONS AND AS NOTIFIED TO EFSA 
EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
 Bacteria    
FEEDAP Actinoplanes utahensis Production of 
acarbose 
EFSA-Q-2007-172 
The EFSA Journal (2008) 839, 1-40 
www.efsa.europa.eu/en/scdocs/scdoc/839.htm 
 
No body of knowledge, therefore not 
appropriate for QPS (EFSA, 2008). 
Full safety assessment was performed in 
FEEDAP Opinion. 




The EFSA Journal (2011) 9(1):1954 
www.efsa.europa.eu/en/efsajournal/doc/1954.pdf 
Actinomadura yumaensis produce antibiotics, 
are therefore inappropriate for QPS (EFSA 
opinion 2008) 
FEEDAP Alcaligenes acidovorans  





The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
No body of knowledge, therefore not 
appropriate for QPS (EFSA, 2008). 
Full safety assessment was performed in 
FEEDAP Opinion. 
FEEDAP Bacillus amyloliquefaciens Feed additive EFSA-Q-2007-190 





EFSA Journal 2010;8(12):1918 [2 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1918.htm 
 
EFSA-Q-2011-00389 (In progress) 
Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). The possibility 
that new virulence factors, with activities 
different from those described previously could 
be discovered should be kept under attention 
(2008, 2009, 2010).  
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 











EFSA-Q-2010-01295 (under consideration) 
EFSA-Q-2010-01297 (under consideration) 
FAD-2010-0367 (formal mandate to arrive) 
 





No Draft Assessment Report received – no EFSA 
Question yet 
 
FEEDAP Bacillus brevis  
= Aneurinibacillus and Brevibacillus 
species 
Strains from B. brevis are now mostly 
Brevibacillus species and some are 








No sufficient body of knowledge and safety 
concern because of antibiotic production. 
Therefore not appropriate for QPS (EFSA, 
2008). It will no longer be assessed for the QPS 
list unless new notification to EFSA (2010). 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Bacillus cereus var. toyoi 
= B. cereus 
 
Feed additive EFSA-Q-2003-086 
























EFSA-Q-2010-01095 (in progress) 
EFSA-Q-2011-00832 (in progress) 
QPS status inapplicable for the group of B. 
cereus strains (see EFSA opinion 2007, 
Appendix B, EFSA, 2008). There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Bacillus coagulans Feed additive  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention (2008, 2009, 2010).  
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Bacillus firmus = Brevibacillus agri Biomass for 
animal feed 
EFSA-Q-2004-171 
The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
No body of knowledge, therefore not 
appropriate for QPS (EFSA 2008). It will no 
longer be assessed for the QPS list unless new 
notification to EFSA (2010). 
Pesticides Bacillus firmus I-1582 Plant protection 
product 
New active substance. 
Draft assessment report received. 
No EFSA question number yet 
A reassessed of this species will be carried in 
the QPS 2012 review. 
FEEDAP Bacillus lentus Feed additive  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). 
The possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention (2008, 2009, 2010).  






22 June 2000 






food colours and 
some vitamins) 
 Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). The possibility 
that new virulence factors, with activities 
different from those described previously could 
be discovered should be kept under attention 
(2008, 2009, 2010).  
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Bacillus licheniformis  Feed additive EFSA-Q-2006-136 (adopted) 




EFSA-Q-2007-166 (in progress) 
EFSA-Q-2009-00970 (in progress) 
EFSA-Q-2009-00680 (in progress) 
Qualification: Absence of toxigenic potential 
(see EFSA opinions, 2008, 2009, 2010). The 
possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention (2008, 2009, 2010).  
FEEDAP Bacillus megaterium Production of 
vitamin C 
 
EFSA-Q-2010-01290 (in progress) Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). The possibility 
that new virulence factors, with activities 
different from those described previously could 
be discovered should be kept under attention 
(2008, 2009, 2010).  
FEEDAP Bacillus pumilus Feed additive  Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). The possibility 
that new virulence factors, with activities 
different from those described previously could 
be discovered should be kept under attention 
(2008, 2009, 2010).  
Pesticides  Bacillus pumilus 
strain QST 2808 
Plant protection 
product 
No Draft Assessment Report received – no EFSA 
Question yet. 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 


















EFSA-Q-2007-166 (in progress) 
 
EFSA-Q-2007-040  















Already QPS (EFSA, 2007). Qualification: 
Absence of toxigenic potential (see EFSA 
opinions, 2008, 2009, 2010). The possibility 
that new virulence factors, with activities 
different from those described previously could 
be discovered should be kept under attention 
(2008, 2009, 2010).  
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Bacillus subtilis Feed additive EFSA-Q-2009-00680 (in progress) 
EFSA-Q-2009-00525 (In progress) 
 
EFSA-Q-2010-00814 








EFSA Journal 2011;9(3):2114  
www.efsa.europa.eu/en/efsajournal/pub/2114.htm 
 




EFSA-Q-2010-00991 (GMM, in progress) 
EFSA-Q-2010-01319 (GMM, in progress) 
 




FAD-2010-0367 (formal mandate to arrive) 
EFSA-Q-2007-0020: 
www.efsa.europa.eu/en/efsajournal/pub/1156.htm 








EFSA-2010-01298 (GMM in progress) 
 
Pesticides Bacillus subtilis 
Strain QST 713 
Plant protection 
product 
EFSA-Q-2008-492 (In progress) Qualification: Absence of toxigenic potential 
(see EFSA opinions, 2008, 2009, 2010). The 
possibility that new virulence factors, with 
activities different from those described 
previously could be discovered should be kept 
under attention (2008, 2009, 2010).  
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
Pesticides Bacillus subsp. thuringiensis aizawai 
 (strains ABTS 1857 and GC-91) 





EFSA-Q-2009-00121 (In progress) 




Already considered as not appropriate for QPS 
(see EFSA opinion, 2007). There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
Pesticides Bacillus subsp. thuringiensis 
israelensis  
(serotype H-14), strain AM 6552 




EFSA-Q-2009-00122 (in progress) 




Already considered as not appropriate for QPS 
(see EFSA, 2007). There is increasing evidence 
of pathogenicity, and this species will not longer 
be assessed unless new scientific information 
becomes available. 
Pesticides Bacillus subsp. thuringiensis kurstaki 
(strains ABTS 351, PB 54, SA11, SA 
12, EG 2348) 




EFSA-Q-2009-00123 (in progress) 




Already considered as not appropriate for QPS 
(see EFSA, 2007). There is increasing evidence 
of pathogenicity, and this species will not longer 
be assessed unless new scientific information 
becomes available. 
Pesticides Bacillus subsp. thuringiensis 
tenebrionis  
(strain NB176 (TM 141)) 




EFSA-Q-2009-00124 (in progress) 
EFSA-Q-2009-00250 (In progress) 
 
Already considered as not appropriate for QPS 
(see EFSA, 2007). There is increasing evidence 
of pathogenicity, and this species will not longer 
be assessed unless new scientific information 
becomes available. 
FEEDAP Bifidobacterium animalis  Feed additive EFSA-Q-2006-00169 (In progress) 
EFSA-Q-2009-00823 (In progress) 
EFSA-Q-2009-00817 (In progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Bifidobacterium longum Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 




biomass for feed 
EFSA-Q-2007-157 (Additional data requested) The recipient species is QPS for production 
purposes only, but not for this application, 
therefore not appropriate for QPS 
(EFSA, 2008 opinion) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)







Clostridium butyricum Feed additive EFSA-Q-2008-303 





EFSA Journal 2011;9(1):1951 [15 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1951.htm 
No history of use, possible production of 
botulinum toxins, therefore not appropriate for 
QPS (EFSA, 2008) 
FEEDAP Corynebacterium glutamicum Production of L-
Arginin 
EFSA-Q-2006-031 
The EFSA Journal (2007) 473, 1-19 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620781637.htm 
QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 
FEEDAP Corynebacterium glutamicum Production of L-
lysine 
production 
EFSA-Q-2010-01301 (in progress) 
 
EFSA-Q-2010-01036 (in progress) 
QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 
FEEDAP Corynebacterium glutamicum Production of L-
Tryptophan 
EFSA-Q-2010-01026 (in progress) QPS status applies only when the species is used 
for production purposes (EFSA opinion, 2007) 




Formal mandate still to arrive 
 
Not recommended for the QPS list, QPS 2011 
update due to insufficient body of knowledge 




Formal mandate still to arrive  
 
Not recommended for the QPS list, QPS 2011 
update due to insufficient body of knowledge 
FEEDAP Enterococcus faecium Feed additive EFSA-Q-2003-087 












The EFSA Journal (2004) 120, 1-4 
No taxonomical unit within Enterococcus can be 
considered as free of infectious strains. 
Therefore no recommendation for QPS status 
(EFSA, 2007, 2008, 2009, 2010). There is 
increasing evidence of pathogenicity, and this 
species will not longer be assessed unless new 
scientific information becomes available (2010). 
QPS 2011 update 
 
EFSA Journal 2011;9(12):2497 58
EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)






















The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2006-169 (in progress)  
 
EFSA-Q-2006-135 








The EFSA Journal (2009) 990, 1-12 
www.efsa.europa.eu/en/scdocs/scdoc/990.htm 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)




EFSA-Q-2008-471 (in progress) 
EFSA-Q-2008-422 
EFSA Journal 2010; 8(7):1661 [13 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1661.htm 
 
EFSA-Q-2009-00679 (In progress) 
 
EFSA-Q-2009-00969 (In progress) 
 
EFSA-Q-2009-00823 (In progress) 
 
EFSA-Q-2009-00202 (In progress) 
 
EFSA-Q-2010-00070 
EFSA Journal 2010; 8(6): 1636 [5 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1636.htm 
 
EFSA-Q-2010-00009 (in progress) 
EFSA-Q-2010-00071 (in progress) 
EFSA-Q-2011-00203 (in progress) 
FEEDAP Enterococcus mundtii Feed additive  No taxonomical unit within Enterococcus can be 
considered as free of infectious strains. 
Therefore no recommendation for QPS status 
(EFSA opinion, 2007) 
GMO Escherichia coli Dried killed 
biomasses for 
feed 
EFSA-Q-2008-412a and EFSA-Q-2008-669a 
(Additional data requested) 
QPS 2009, 2010 update. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 




EFSA-Q-2008-412b and EFSA-Q-2008-669b 
(Additional data requested) 
QPS 2009, 2010 update. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
QPS 2011 update 
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Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Escherichia coli Feed additive L-
threonine 
production 
EFSA-Q-2010-01067 (In progress); 
EFSA-Q-2010-01034 (In progress);  
EFSA-Q-2010-1314 (In progress); 
EFSA-Q-2010-01305 (In progress) 
QPS 2009, 2010 update. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Escherichia coli Feed additive L-
tryptophan 
production 
EFSA-Q-2010-01310, (In progress); 
EFSA-Q-2010-01026 (In progress); 
EFSA-Q-2010-01306 (In progress) 
QPS 2009, 2010 update. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 
FEEDAP Escherichia coli Feed additive  
(horses) 
EFSA-Q-2005-167 
The EFSA Journal (2009) 989, 1-14 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902391773.htm 
QPS 2009, 2010 update. There is increasing 
evidence of pathogenicity, and this species will 
not longer be assessed unless new scientific 
information becomes available. 





The EFSA Journal (2005) 169, 1-14 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620782757.htm 
No body of knowledge. Already given a 
negative assessment by FEEDAP. Not 
appropriate for QPS 
(EFSA opinion 2008) 
FEEDAP Ketogulonicigenium vulgare Production of 
vitamin C 
 
EFSA-Q-2011-00250 (in progress) Not recommended for the QPS list, QPS 2011 
update due to insufficient body of knowledge 
FEEDAP Lactobacillus acidophilus Feed additive EFSA-Q-2003-115  








The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2008-377 (in progress) 
 
EFSA-Q-2010-00071 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus amylolyticus Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Lactobacillus amylovorans Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus brevis Feed additive EFSA-Q-2010-01304 (under consideration) 
EFSA-Q-2011-00382 (in progress) 
EFSA-Q-2011-00385 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacilllus buchneri Feed additive EFSA-Q-2010-01276 
EFSA Journal 2011;9(4):2138  
www.efsa.europa.eu/en/efsajournal/pub/2138.htm  
 
EFSA-Q-2011-00375 (in progress) 
EFSA-Q-2011-00376 (in progress) 
EFSA-Q-2011-00382 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus bulgaricus 
 = L. delbrueckii subsp. bulgaricus 
Feed additive EFSA-Q-2006-135  
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2010-00071 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus casei (note: this species 
is very rare and its identity might 
need to be verified) 
Feed additive EFSA-Q-2011-00381(in progress) 
 
EFSA-Q-2011-00390 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus casei rhamnosus 
= Lactobacillus rhamnosus 
Feed additive EFSA-Q-2011-00380 (in progress) Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus cellobiosus Feed additive  Not initially considered for QPS (see EFSA 
opinions 2007, 2008). QPS recommended 2009, 
2010 
FEEDAP Lactobacillus collinoides Feed additive  Not initially considered for QPS status (see 
EFSA opinions 2007, 2008). QPS recommended 
2009, 2010 
FEEDAP Lactobacillus delbrueckii subsp. 
lactis 
Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Lactobacillus farciminis Feed additive EFSA-Q-2006-062 




The EFSA Journal (2006) 377, 1-6 
www.efsa.europa.eu/en/scdocs/scdoc/377.htm 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus fermentum Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus helveticus Feed additive EFSA-Q-2006-135  
The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2010-00071 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus mucosae Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus paracasei Feed additive EFSA-Q-2011-00378 (in progress) 
EFSA-Q-2011-00387 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus pentosus 
 
Feed additive EFSA-Q-2011-00388 (in progress) Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus plantarum Feed additive EFSA-Q-2010-01164  




EFSA Journal 2011;9(6):2275  
www.efsa.europa.eu/en/efsajournal/pub/2275.htm 
 
EFSA-Q-2011-00125 (in progress) 
EFSA-Q-2011-00186 (in progress) 
EFSA-Q-2011-00374 (in progress) 
EFSA-Q-2011-00377 (in progress) 
EFSA-Q-2011-00384 (in progress) 
EFSA-Q-2011-00390 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
QPS 2011 update 
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Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Lactobacillus reuteri Feed additive EFSA-Q-2003-010 
The EFSA Journal (2005) 229, 1-7 
www.efsa.europa.eu/en/scdocs/scdoc/229.htm 
 
EFSA-Q-2006-169 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus rhamnosus Feed additive EFSA-Q-2006-062 
The EFSA Journal (2008) 771, 1-13 
www.efsa.europa.eu/en/scdocs/scdoc/771.htm 
 
EFSA-Q-2011-00125 (in progress) 
EFSA-Q-2011-00380 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
Lactobacillus rhamnosus is recommended for 
the QPS list, and remains a topic for 
surveillance. 
FEEDAP Lactobacillus sakei Feed additive  Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactobacillus salivarius Feed additive EFSA-Q-2006-169 (in progress) 
EFSA-Q-2009-00823 (In progress) 
EFSA-Q-2011-00381 (In progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Lactococcus lactis  Feed additive EFSA-Q-2006-135 
www.efsa.europa.eu/en/efsajournal/pub/912.htm 
 
EFSA-Q-2010-00071 (in progress) 
EFSA-Q-2010-00901 (in progress) 
EFSA-Q-2011-00373 (in progress) 
EFSA-Q-2011-00383 (in progress) 
Already QPS (EFSA, 2007, 2008, 2009, 2010) 
Attention should be focused on human clinical 
cases without underlying predisposing factors 
(EFSA, 2011). 
2001/122/EC Leuconostoc mesenteroides Production of 





 Already QPS (EFSA, 2007, 2008, 2009, 2010) 
FEEDAP Leuconostoc oeno = Oenococcus oeni Feed additive  Not initially considered for QPS (see EFSA 
opinion 2007, 2008) and  recommended for the 
QPS list in 2009, 2010 (EFSA, 2009; 2010) 
FEEDAP Leuconostoc pseudomesenteroides Feed additive  Not recommended for QPS (see EFSA opinions 
2007, Appendix A; 2009; 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Methylococcus capsulatus Biomass for 
animal feed 
EFSA-Q-2004-171 
The EFSA Journal (2005) 230, 1-6 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620784006.htm 
No body of knowledge, therefore not 




Paenibacillus macerans b-cyclodextrin 
production 
(food additive) 
 QPS 2009 update not recommended for QPS 
because of insufficient body of knowledge. It 
will no longer be assessed for the QPS list 
unless new notification to EFSA. 
 










EFSA Journal 2010; 8(1):1428 [8 pp.]. 
www.efsa.europa.eu/en/efsajournal/pub/1428.htm 
No body of knowledge, therefore not considered 
for QPS (EFSA, 2008) 
QPS 2011 update 
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microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 





















EFSA Journal 2010;8(10):1865 
www.efsa.europa.eu/en/scdocs/scdoc/1865.htm 
 
EFSA-Q-2011-00379 (in progress) 
Already QPS 
FEEDAP Pediococcus pentosaceus Feed additive EFSA-Q-2009-00717 
EFSA Journal 2010; 8(2):1502 
www.efsa.europa.eu/en/scdocs/scdoc/1502.htm 
 
EFSA-Q-2011-00386  (in progress) 
Already QPS 
FEEDAP Propionibacterium acidipropionici Feed additive EFSA-Q-2011-00953 (in progress) Not proposed for QPS status (see EFSA opinion 
2007, Appendix A). In 2009, 2010 
recommended for the QPS list (EFSA, 2009; 
2010). 
QPS 2011 update 
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microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Propionibacterium freudenreichii 
shermanii 
Feed additive  Already QPS 




Formal mandate still to arrive  
 
Already QPS 
FEEDAP Propionibacterium globosum  
[=subspecies of Propionibacterium 
freudenreichii] 
Feed additive  Not recommended for QPS (see EFSA opinion 
2007, Appendix A). Identical with P. 
freudenreichii therefore included  on QPS 
(EFSA, 2010) 
Pesticides Pseudomonas sp. DSMZ 13134 Plant Protection 
Product 
Draft Assessment Report: no further info on the 
species. It is considered as a new species within 
the RNA-group I-pseudomonads. 
No EFSA question number yet. 
Not assessed because species to be clarified 
(EFSA, 2009) 





Not recommended for QPS in QPS 2009 update 
because of insufficient body of knowledge and a 
potential risk linked to production of secondary 
metabolites. It will no longer be assessed for the 
QPS list unless new notification to EFSA. 
 
 
FEEDAP Rhodopseudomonas palustris Feed additive  Insufficient body of knowledge (EFSA 2009). It 
will no longer be assessed for the QPS list 
unless new notification to EFSA. 
 
FEEDAP Serratia rubidaea Feed additive  Insufficient body of knowledge (EFSA 2009). It 
will no longer be assessed for the QPS list 
unless new notification to EFSA. 
 
FEEDAP Streptococcus cremoris = L. lactis 
subsp. cremoris 
Feed additive  Already QPS 
QPS 2011 update 
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Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Streptococcus faecium  
= Enterococcus faecium 
Feed additive  No taxonomical unit within Enterococcus can be 
considered as free of infectious strains. 
Therefore no recommendation for QPS status 
(EFSA opinion, 2007, 2008, 2009, 2010).  
There is increasing evidence of pathogenicity, 
and this species will not longer be assessed 
unless new scientific information becomes 
available. 
FEEDAP Streptococcus thermophilus Feed additive EFSA-Q-2006-135  
www.efsa.europa.eu/en/scdocs/scdoc/912.htm 
 
EFSA-Q-2010-00071 (in progress) 
Already QPS 




The EFSA Journal (2008) 912, 1-13 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783414.htm 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 





The EFSA Journal (2004), 90, 1-44 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783396.htm 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 




The EFSA Journal (2004), 42, 1-61 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783743.htm 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 
Pesticides Now unspecified Streptomyces 
species : ‘Streptomyces strain K 61’ 





EFSA-Q-2009-00134 (In progress) 




Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion, 
2008) 
FEEDAP Streptomyces lasaliensis Production of 
lasalocid sodium 
EFSA-Q-2004-076 
The EFSA Journal (2004) 77, 1-45 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783432.htm 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008) 
QPS 2011 update 
 
EFSA Journal 2011;9(12):2497 68
EFSA 
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microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
Pesticides Streptomyces lydicus 
strain WYEC 108 (ATCC 55445) 
Plant protection 
product 
No Draft Assessment Report received – no EFSA 
Question yet. 
Streptomyces spp. produce antibiotics, are 
therefore inappropriate for QPS (EFSA opinion 
2008).  
 Yeasts    
Pesticides  Aureobasidium pullulans strains 
DSM 14940 and DSM 14941 
Plant Protection 
Product 
EFSA-Q-2010-01499 (in progress) 
 
Body of knowledge insufficient (QPS 2009 
update) 
FEEDAP Candida glabrata Feed additive  Unsuitable for QPS (see EFSA opinion 2007, 
Appendix C) 




Unsuitable for QPS (see EFSA opinion 2007, 
Appendix C) 
Pesticides Candida oleophila strain O Plant protection 
product 




Body of knowledge insufficient, therefore not 
appropriate for QPS 
(EFSA opinion 2008) 





The EFSA Journal (2006) 333, 1-27 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620769671.htm 
Already QPS status applies only when species is 




Kluyveromyces marxianus var. 
lactisK1 





Kluyveromyces marxianus-fragilis Feed additive  Already QPS 
FEEDAP Astaxanthin rich Phaffia rhodozyma 









The EFSA Journal (2004) 43, 1-4 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620783707.htm 
Phaffia rhodozyma was assessed not appropriate 
for QPS (EFSA opinion 2008) because of 
insufficient body of knowledge. Later 
recommended for the QPS list (EFSA, 2011) as 
it is the imperfect form of Xanthophyllomyces 
dendrorhous according to the 2011 revision of 
the yeast taxonomy.  
QPS 2011 update 
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and related opinions: 
EFSA-Q-2009-00804: 
www.efsa.europa.eu/en/efsajournal/pub/1550.htm 
EFSA-Q-2010-00152 (GMM, additional data 
request) 
 
EFSA-Q-2011-00148 (in progress) 
 
Other applications: 
EFSA-Q-2010-00152 (GMM, in progress) 
 
















EFSA Journal 2011;9(4):2110 
www.efsa.europa.eu/en/efsajournal/pub/2110.htm  
 
EFSA-Q-2010-01029 (in progress) 
 
FEEDAP Saccharomyces cerevisiae Production of 
Enzyme 
EFSA-Q-2005-224 and EFSA-Q-2009-00534 
(GMM, in progress) 
 
FEEDAP Saccharomyces cerevisiae Feed additive EFSA-Q-2005-025 
www.efsa.europa.eu/en/efsajournal/pub/384.htm 
 
Already QPS (EFSA Opinions 2007, 2008, 
2009, 2010). 
QPS 2011 update 
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Genus and species of 
microorganism as notified 
(current taxonomy where different)




































The EFSA Journal (2008) 837, 1-10 
www.efsa.europa.eu/en/scdocs/scdoc/837.htm 
QPS 2011 update 
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EFSA Journal 2010;8(7):1659 
www.efsa.europa.eu/en/scdocs/scdoc/1662.htm 
 
EFSA-Q-2009-00818 (In progress) 
 
EFSA-Q-2009-00824 
EFSA Journal 2010;8(7):1662 
www.efsa.europa.eu/en/scdocs/scdoc/1662.htm 
 
EFSA-Q-2010-00938 (in progress) 
 




EFSA-Q-2011-00390  (in progress) 
GMO Saccharomyces cerevisiae Dried killed 
biomass for feed 
EFSA-Q-2007-156b (under consideration) 
EFSA-Q-2009-00866 (Waiting for full dossier) 
 
QPS 2011 update 
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Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Schizosaccharomyces pombe Production of 
enzymes 
EFSA-Q-2005-063 














EFSA-Q-2011-00835 (in progress) 
Already QPS (EFSA Opinions 2007, 2008, 
2009, 2010). 
 Fungi    
Pesticides Ampelomyces quisqualis Plant protection 
product 
EFSA-Q-2008-489 (in progress) Not recommended for the QPS list, QPS 2011 
update 




Formal mandate still to arrive (GMM) Not recommended for the QPS list, QPS 2011 
update 






EFSA-Q-2010-01297 (in progress) 
EFSA-Q-2010-01295(in progress) 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
FEEDAP Aspergillus niger Feed additive EFSA-Q-2009-00585 (in progress) 
 
EFSA-Q-2009-00534 (in progress) 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
QPS 2011 update 
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Intended use EFSA question number and published opinion  
[additional information] 
Comments 









EFSA-Q-2011-00147 (in progress) 
 
EFSA-Q-2005-116 (GMM) 
The EFSA Journal (2006) 369, 1-19 
www.efsa.europa.eu/en/efsajournal/doc/369.pdf  














and related Questions: 
EFSA-Q-2010-00937 
EFSA Journal 2011;9(5):2172 
www.efsa.europa.eu/en/efsajournal/pub/2172.htm 
 
EFSA-Q-2010-01519 (in progress) 
FAD-2010-0367 (formal mandate to arrive) 
EFSA-Q-2011-00061 (in progress) 
 
QPS 2011 update 
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Comments 






















EFSA-Q-2008-419 (GMM, in progress) 
 
EFSA-Q-2010-00769 (in progress) 
 
EFSA-Q-2010-01519 (GMM, in progress) 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
FEEDAP Aspergillus oryzae Feed additive  EFSA-Q-2009-00525 (in progress) 
 
Potential for mycotoxin production, therefore 
not suitable for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
Pesticides Beauveria bassiana 
(ATCC-74040 and GHA)  
Plant protection 
product 
EFSA-Q-2009-00125 (in progress) 





Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
Pesticides Beauveria brongniartii Plant protection 
product 
EFSA-Q-2009-00017 (in progress) Mycelial fungi: already considered as not 
appropriate for QPS. Insufficient body of 
knowledge, potential oosporein formation 




the register of 
questions) 












The EFSA Journal (2008) 674, 1-66 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178700117557.htm 
Can not be proposed for QPS status (see EFSA 
opinion 2007, Appendix D; EFSA, 2009; EFSA, 
2010) 
FEEDAP Blakeslea trispora Production 
strain for beta-
carotene 
EFSA-Q-2009-00884 (in progress) QPS 2009, 2010 update 
NDA Blakeslea trispora Food ingredient EFSA-Q-2004-169 





The EFSA Journal (2008) 893, 1-15 
www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902228574.htm 
QPS 2009, 2010 update 
Pesticides Coniothyrium minitans Plant protection 
product 
EFSA-Q-2008-515 (in progress) 
 
[Review report for the active substance 




The body of knowledge is insufficient. Potential 
acrosphelide formation (EFSA, 2009; EFSA, 
2010) 
 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
FEEDAP Duddingtonia flagrans 
Alternative name: 
Trichothecium flagrans 
Feed additive EFSA-Q-2004-115 




EFSA-Q-2005-051 under consideration 
Insufficient body of knowledge (EFSA, 2009; 
EFSA, 2010) 
 
Pesticides Gliocladium catenulatum  










No recommendation for QPS in 2009 (EFSA, 
2009). No new relevant information in the 2010 
update. 
Pesticides Lecanicillium muscarium  





EFSA-Q-2009-00130 (in progress) 
EFSA-Q-2009-00255 (finalized on 18/12/2009) 
Conclusion on the peer review (2009): 
www.efsa.europa.eu/en/scdocs/scdoc/1446.htm 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 





EFSA-Q-2009-00131 (in progress) 
EFSA-Q-2009-00253 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
Pesticides Paecilomyces fumosoroseus 
strain FE 9901 (ARSEF 4490)  
Plant protection 
product 
EFSA-Q-2008-599 (in progress) 




Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 





EFSA-Q-2010-01287 in progress) 
EFSA-Q-2011-0026 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
Pesticides Paecilomyces lilacinus 
strain 251  
Plant protection 
product 
EFSA-Q-2008-600 (finalized on 13/06/2007) 
 





Mycelial fungi: already considered as not 
appropriate for QPS. Potential for production of 
peptaibols (see EFSA, 2007; EFSA, 2009; 
EFSA, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
Pesticides Phlebiopsis gigantean 




EFSA-Q-2009-00132 (in progress) 
EFSA-Q-2009-00285 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS. Insufficient body of 
knowledge (see EFSA, 2007; EFSA, 2009; 
EFSA, 2010) 
Pesticides Pseudozyma flocculosa 
strain ATCC 64874 
Plant protection 
product 




Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 




EFSA-Q-2009-00133 (in progress) 




Mycelial fungi: already considered as not 
appropriate for QPS. Insufficient body of 
knowledge (see EFSA, 2007; EFSA, 2009; 
EFSA, 2010) 





EFSA-Q-2011-00899 Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
Pesticides Trichoderma asperellum 
strains ICC 012, T11 and TV1 
Plant protection 
product 
EFSA-Q-2009-00136 (in progress)  
 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 




EFSA-Q-2011-00900 Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 





EFSA-Q-2009-00137 (in progress) 
EFSA-Q-2009-00297 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
Pesticides Trichoderma harzianum Rifai 




EFSA-Q-2009-00139 (in progress) 




Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
FEEDAP Trichoderma longibrachiatum   Feed additive  Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 








EFSA-Q-2008-288 (in progress) 
EFSA-Q-2010-00036 (in progress) 
EFSA-Q-2010-01025 (in progress) 
EFSA-Q-2010-01295 (in progress) 
EFSA-Q-2010-01297 (in progress) 
FAD-2010-0367 (formal mandate to arrive) 
Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
Pesticides Trichoderma polysporum 





EFSA-Q-2009-00140 (in progress) 




Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 





























and related question: 
EFSA-Q-2010-00142 (additional data request) 
 
EFSA-Q-2010-00142  
EFSA Journal 2011;9(6):2277 
www.efsa.europa.eu/en/efsajournal/pub/2277.htm 
Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 




and related questions: 






















EFSA-Q-2011-00804 (in progress) 
Ineligible for QPS status (see EFSA opinion 
2007, Appendix D; EFSA, 2009; EFSA, 2010) 
FEEDAP  Trichoderma viride Production of 
enzyme 
EFSA-Q-2010-01295 (in progress) 
EFSA-Q-2010-01297 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
Pesticides Trichoderma viride 
=Trichoderma gamsii  
strains ICC 080, T25 and TV1 
Plant protection 
product 
EFSA-Q-2009-00138 (in progress) 
EFSA-Q-2009-00300 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS (see EFSA, 2007; EFSA, 
2009; EFSA, 2010) 
QPS 2011 update 
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EFSA 
Panel/Unit 
Genus and species of 
microorganism as notified 
(current taxonomy where different)
Intended use EFSA question number and published opinion  
[additional information] 
Comments 
Pesticides Verticillium albo-atrum  
formerly Verticillium dahliae  
Plant protection 
product 
EFSA-Q-2009-00141 (in progress) 
EFSA-Q-2009-00303 (in progress) 
Mycelial fungi: already considered as not 
appropriate for QPS. Potential production of 
alboatrin (see EFSA, 2007; EFSA, 2009; EFSA, 
2010) 
FEEDAP Trichosporon mycotoxinivorans Feed additive EFSA-Q-2010-01030 (The application has been 
withdrawn) 
Not recommended for the QPS list, assessed in 
the current 2011 update 
 Algae    
FEEDAP Haematococcus pluvialis Production of 
astaxanthin 
 No body of knowledge except for this strain. 
Therefore not considered for QPS 
(EFSA opinion 2008) 
 Bacteriophages    
FEEDAP Clostridium sporogenes phage Feed additive  QPS 2009, 2010 updates 
FEEDAP Clostridium tyrobutyricum phage Feed additive  QPS 2009, 2010 updates 
 Viruses    




EFSA-Q-2009-00324 (in progress) 
 
QPS 2009, 2010 update 




EFSA-Q-2009-00126 (in progress) 
EFSA-Q-2009-00254 (in progress) 
[www.epa.gov/opp00001/biopesticides/ 
ingredients/factsheets/factsheet_107300.htm] 
QPS 2009, 2010 update 




EFSA-Q-2009-00341 (in progress) 
 
QPS 2009, 2010 update 




EFSA-Q-2008-630 (in progress) QPS 2009, 2010 update 




EFSA-Q-2009-00507 (in progress) QPS 2009, 2010 update 




EFSA-Q-2009-00346 (in progress) 
[www.epa.gov/opp00001/biopesticides/ 
ingredients/factsheets/factsheet_244201.htm] 
QPS 2009, 2010 update 
Glossary 
Yeast Synonyms commonly used in the feed/food industry 
 Wickerhamomyces anomalus: synonym Hansenula anomala, Pichia anomola, Saccharomyces anomalus 
 Pichia jadinii: anamorph Candida utilis; synonyms Hansenula jadinii, Torulopsis utilis 
 Saccharomyces cerevisiae synonym S. boulardii 
 Saccharomyces pastorianus: synonym of Saccharomyces carlsbergensis 
 Komagataella pastoris: synonym Pichia pastoris 
QPS 2011 update 
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